Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7733764863103352,1.8499090100101685,0.0,0.15743549304040053,0.139,6/21,13.21%,FGF20;FGF9;FGF10;FRS2;KL;NPTN
prerank,anion transmembrane transporter activity (GO:0008509),-0.6820169813758874,-1.8264189354279057,0.0033112582781456954,0.6275478690549722,0.354,5/12,12.10%,ABCG2;SLC39A8;SLC22A6;SLC26A11;SLC4A2
prerank,diacylglycerol kinase activity (GO:0004143),-0.6664190407651701,-1.758740180050763,0.011730205278592375,0.6269302038295244,0.594,7/11,12.04%,DGKH;AGK;DGKB;DGKE;DGKZ;DGKD;DGKG
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7639076941453007,1.7457017874739196,0.002777777777777778,0.5304076729813495,0.608,1/15,0.14%,PLA2G5
prerank,phosphatidate phosphatase activity (GO:0008195),0.7702117098564835,1.7303925965460916,0.005865102639296188,0.45106518244114757,0.68,8/13,15.83%,LPIN1;PLPPR2;LPIN3;LPIN2;PLPP3;PLPPR5;PLPP4;PLPP5
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.681578531078362,1.665964554426763,0.007643312101910828,0.8007656476370372,0.943,9/22,12.39%,ILF3;CPEB1;KHSRP;ZFP36L1;EXOSC8;RBMS3;DHX36;NUDT21;HNRNPA0
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.8023631032421787,1.6637080255066068,0.0074962518740629685,0.6606668011516807,0.948,1/10,0.02%,DPYSL4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5834725770752408,1.6626807801289847,0.0021436227224008574,0.5572716658414177,0.95,11/73,11.05%,FSHR;S1PR2;LTB4R2;VIPR2;OPRK1;HCRTR2;GPR37;BDKRB2;LGR4;PTH1R;HCRTR1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5773474505238252,-1.66214336638878,0.022222222222222223,0.7285361334156887,0.861,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5773474505238252,-1.66214336638878,0.022222222222222223,0.7285361334156887,0.861,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,CXCR chemokine receptor binding (GO:0045236),0.7889449255262715,1.6603001727703564,0.004464285714285714,0.49278915806268225,0.954,2/11,4.50%,YARS1;CXCL12
prerank,solute:sodium symporter activity (GO:0015370),0.6584551593751015,1.6550526849015432,0.008526187576126675,0.46106108676117297,0.963,4/27,5.03%,SLC4A4;SLC4A5;SLC5A3;SLC20A2
prerank,hormone activity (GO:0005179),0.5964378398045883,1.6469365009765677,0.002224694104560623,0.4512734304478147,0.972,5/54,3.71%,APLN;IGF1;EDN3;GNRH1;PTHLH
prerank,filamin binding (GO:0031005),0.7787029623745171,1.6362834710623104,0.005813953488372093,0.4578748922591649,0.984,1/11,0.02%,DPYSL4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6658643734683463,-1.6357672647373191,0.02564102564102564,0.7110562075355157,0.913,4/10,11.66%,SLCO3A1;SLCO1C1;SLCO2A1;SLC22A6
prerank,peptide hormone receptor binding (GO:0051428),0.7585582900267993,1.6260143848628676,0.011494252873563218,0.4716249401902907,0.99,3/11,10.46%,GNRH1;PTHLH;PSMC5
prerank,exoribonuclease activity (GO:0004532),0.7450865249931392,1.6201393936248445,0.01634472511144131,0.46301341182367795,0.994,5/12,6.42%,EXOSC1;EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,anion:anion antiporter activity (GO:0015301),-0.5408068039893004,-1.614567075229001,0.02214022140221402,0.6950792670372659,0.942,8/17,28.01%,SLC26A7;SLC26A2;SLC25A4;SLC26A11;SLC4A2;SLC4A3;SLC25A11;SLC25A5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5470049043605842,1.596671542802614,0.0021253985122210413,0.5526822001560214,0.998,35/78,19.59%,SFRP1;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;CAPN10;USP24;USP47;USP42;CAPN5;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;USP40;USP9X;PIGK;CTSZ;CASP2;USP34;USP35;CTSH;USP48;CAPN15;CAPNS1;USP33;CTSK;CTSO;USP37
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7086502093308715,1.591830329498904,0.02263083451202263,0.5395110858442297,0.999,3/14,8.41%,RDH10;RDH11;RDH5
prerank,aspartic-type peptidase activity (GO:0070001),-0.6525485146869734,-1.5881145043627167,0.015060240963855422,0.7143739521750639,0.967,3/10,8.71%,BACE2;BACE1;DDI2
prerank,C-C chemokine receptor activity (GO:0016493),0.654848076471265,1.5783798315830722,0.015463917525773196,0.5720156247134552,1.0,3/21,7.14%,CCR9;ACKR2;CXCR4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7303960625638374,1.569832716949267,0.03106508875739645,0.5831204496689835,1.0,2/11,4.12%,SLC17A5;SLC5A3
prerank,cysteine-type peptidase activity (GO:0008234),0.5411050959448841,1.5595448148607602,0.006472491909385114,0.6071409384968387,1.0,34/73,19.59%,OTULINL;SFRP1;ATG4A;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;USP24;USP47;USP42;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;GGH;USP40;USP9X;CTSZ;CASP2;USP34;USP35;CTSH;USP48;USP33;CTSK;CTSO;USP50;USP37
prerank,frizzled binding (GO:0005109),0.5999979132751417,1.5563871216465057,0.014150943396226415,0.5913202149315044,1.0,8/34,11.52%,WNT2B;WNT5A;SFRP1;DVL2;DVL1;WNT4;SDCBP;ZNRF3
prerank,protein phosphatase 2A binding (GO:0051721),-0.47263496650455517,-1.5551402484331367,0.04979253112033195,0.7847436689314392,0.986,8/23,8.90%,MFHAS1;DAB2IP;PPME1;CTTNBP2NL;ENSA;STRN4;SMG5;TP53
prerank,amino acid:sodium symporter activity (GO:0005283),0.7288137162762874,1.548830449591539,0.030656934306569343,0.5997049373052099,1.0,6/11,17.80%,SLC6A11;SLC1A3;SLC6A15;SLC6A12;SLC6A13;SLC1A2
prerank,vinculin binding (GO:0017166),-0.6060087164352465,-1.5479067501564414,0.05198776758409786,0.7298057786013313,0.989,5/11,6.84%,UTRN;SORBS3;PXN;ACTN1;DMD
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.7367337361584088,1.5369857527762985,0.04682779456193353,0.63677034238662,1.0,2/10,0.62%,CDKN2D;HEXIM1
prerank,hexosyltransferase activity (GO:0016758),0.5232669338923448,1.5342247278218022,0.0031120331950207467,0.6221557947758686,1.0,22/101,12.71%,ALG5;B3GALNT1;TMTC4;A4GALT;B3GLCT;ALG6;GBA2;CHPF;OGT;PIGM;MGAT4B;ALG1;TMTC1;POMGNT1;CHSY3;MGAT4C;POMT2;GBE1;DPY19L1;DPY19L3;ALG9;B4GALT5
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.446068526080289,-1.5329877059309927,0.034653465346534656,0.7251389746757257,0.992,7/28,11.99%,DAB2IP;CASP8AP2;STAT1;RIPK1;FEM1B;TRAP1;MADD
prerank,neuropeptide receptor binding (GO:0071855),0.6923262450632376,1.5282302217045947,0.03347280334728033,0.6249711996452263,1.0,2/14,9.10%,APLN;NMU
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5434698952264746,-1.5279668449344337,0.06206896551724138,0.6842607670279073,0.994,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,dynactin binding (GO:0034452),0.6857915220554625,1.5224058173105373,0.049204052098408106,0.6284789027298598,1.0,7/12,13.93%,SPTBN5;SNX5;SNX6;HOOK3;BICDL1;HTT;MAPT
prerank,C-C chemokine binding (GO:0019957),0.6243686965345274,1.5156076177308835,0.029525032092426188,0.637941737424123,1.0,3/22,7.14%,CCR9;ACKR2;CXCR4
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6986148877775844,1.5135382733401206,0.049635036496350364,0.6237444295695869,1.0,6/12,10.08%,IGF1;PIK3R1;ARRB1;YWHAH;GNAS;YWHAG
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5391589154382641,-1.5009148075345866,0.03859649122807018,0.7419188799670579,0.999,7/15,22.35%,COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1;COX15
prerank,calcium channel inhibitor activity (GO:0019855),0.7109541678587903,1.494125152863443,0.0391304347826087,0.704422911167946,1.0,4/11,9.62%,TNNI3;ITPR1;PACSIN3;SLC30A1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6555177845529533,1.4869676738361595,0.05758426966292135,0.718316790997383,1.0,2/15,3.24%,CCR9;ACKR2
prerank,poly(A) binding (GO:0008143),0.622260304405648,1.4834363393987129,0.05019815059445178,0.713312640980029,1.0,10/21,15.96%,DDX3X;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL
prerank,mannosyltransferase activity (GO:0000030),0.6083906663206673,1.480204696234725,0.04423592493297587,0.7063916005466248,1.0,12/21,21.10%,TMTC4;PIGM;ALG1;ALG8;TMTC1;POMT2;DPY19L1;DPY19L3;ALG9;DPM1;DPY19L4;PIGB
prerank,rRNA binding (GO:0019843),-0.38589751026338504,-1.4783099948658132,0.034482758620689655,0.7816790991590251,0.999,30/42,37.36%,CAVIN1;RPL11;MRPS27;RPL5;PTCD3;RPS13;DDX21;RPLP0;ERI1;RPS5;RPL12;MRPS18A;MRPS18C;FASTKD2;NOP53;MTERF4;RPF2;RPS14;ERAL1;EMG1;NGRN;MRPS7;MRPL18;UTP23;MRPL16;MRPS11;RRS1;PPAN;GTF3A;RPL23
prerank,symporter activity (GO:0015293),0.7028319462427559,1.466438361119217,0.06537890044576523,0.7647179176829455,1.0,1/10,0.31%,SLC4A4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6509991455651811,1.4632313366520573,0.05241379310344828,0.7590337547525762,1.0,5/14,17.19%,CAPN10;CAPN5;CAPN2;CAPN15;CAPNS1
prerank,phosphatase activity (GO:0016791),0.501759508067256,1.4615528025191056,0.016163793103448277,0.7449486741000202,1.0,24/73,16.22%,DUSP28;DUSP18;DUSP26;APTX;ENOPH1;PTPMT1;LPIN1;HDDC2;ATP1A2;PLPPR2;LPIN3;PRUNE1;PPP1CC;HDHD2;LPIN2;PLPP3;PTPN22;PLPPR5;EPHX2;PPP5C;SACM1L;PLPP4;PLPP5;NUDT16L1
prerank,chemokine receptor activity (GO:0004950),0.5892789723120471,1.460644438530031,0.05170239596469105,0.7274292189254871,1.0,3/24,7.14%,CCR9;ACKR2;CXCR4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5440298859315181,1.454345864020171,0.04807692307692308,0.7411485307871797,1.0,15/37,12.81%,FARSB;YARS1;WARS1;YARS2;CARS1;SARS2;GARS1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,histone deacetylase activity (GO:0004407),0.6109935144579693,1.4491746582480713,0.07304116865869854,0.7470153496304719,1.0,7/19,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;HDAC1
prerank,metalloendopeptidase activity (GO:0004222),0.5063944893987066,1.4452683089732283,0.023231256599788808,0.7480008089477362,1.0,13/76,10.62%,ADAMTSL2;MMP12;MMP17;MMP11;ADAMTS7;NRDC;ADAMTS10;ADAMTS20;THOP1;ADAMTS5;ADAMTS6;ADAM33;AFG3L2
prerank,ribosomal large subunit binding (GO:0043023),0.6751595963250091,1.4403477120435446,0.07122093023255814,0.7560500165297612,1.0,7/11,17.69%,RBM3;DHX33;NEMF;MALSU1;NPM1;MRRF;CPSF6
prerank,transaminase activity (GO:0008483),0.680066470818033,1.4351368383667202,0.07342143906020558,0.7657717622008955,1.0,4/11,8.15%,PSAT1;BCAT2;ABAT;OAT
prerank,ion channel inhibitor activity (GO:0008200),0.5424017916606594,1.4256268957969378,0.04964539007092199,0.798999544349725,1.0,16/35,23.39%,TNNI3;ITPR1;PACSIN3;SLC30A1;WNK2;CAMK2D;VTI1B;RACK1;STX8;VAMP8;CALM1;SCN1B;COMMD1;CALM2;WNK3;FKBP1A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5232689868524002,1.4237563995553675,0.04853273137697517,0.7890048414605073,1.0,9/46,10.43%,B3GALNT1;B3GLCT;MGAT3;OGT;MGAT4B;POMGNT1;MGAT4C;EXTL2;PIGA
prerank,pre-mRNA binding (GO:0036002),0.553695123474439,1.4165159092793356,0.06905370843989769,0.8107425048832821,1.0,17/28,22.88%,TARBP2;SLBP;U2AF1;PRPF8;CELF2;CELF1;RBM41;HNRNPL;TRA2B;CELF5;DDX5;RBM22;HNRNPU;PTBP1;RBM7;U2AF2;SRSF6
prerank,gamma-tubulin binding (GO:0043015),0.5851578666168987,1.4156314302492528,0.07178841309823678,0.7963924394970261,1.0,11/22,17.18%,B9D2;CENPJ;DDX3X;ARHGEF7;NDRG1;BRSK1;DIXDC1;BLOC1S2;GIT1;OFD1;TUBGCP2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5382363256934047,1.4106592768393804,0.06968215158924206,0.8046121820392563,1.0,9/32,20.20%,KCNG2;KCNA4;KCNC1;KCNC2;KCNQ4;KCNA1;KCNQ2;KCNH1;KCNA6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.49706580228914193,-1.4101514168047316,0.05387205387205387,1.0,1.0,5/15,20.35%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,omega peptidase activity (GO:0008242),0.4745029862816106,1.409842558369591,0.038381742738589214,0.791011121688376,1.0,38/89,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;ASRGL1;USP2;USP11;USP15;USP3;USP19;GGH;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,receptor ligand activity (GO:0048018),0.46260231517989014,1.409436674746708,0.0010030090270812437,0.7762027952506414,1.0,24/245,10.19%,FGF20;SFRP2;APLN;FGF9;WNT2B;WNT5A;IGF1;IL34;EPHA7;TAFA2;BMP6;NTF3;IL33;EDN3;GNRH1;PTHLH;FGF10;WNT4;LRPAP1;TAFA5;NRG3;EGF;SEMA3D;GDNF
prerank,mechanosensitive ion channel activity (GO:0008381),0.6461701682687608,1.4093709531128982,0.0746054519368723,0.7597566352806285,1.0,2/12,3.55%,TMC5;TMEM63A
prerank,thiol-dependent deubiquitinase (GO:0004843),0.47868146147158536,1.4065580974205858,0.040169133192389,0.7582265614666098,1.0,36/83,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6526527159059375,1.403595690185736,0.08296943231441048,0.7583416240288043,1.0,1/12,1.00%,B3GALNT1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6334054724864344,1.3995172482861413,0.09806835066864784,0.7653751738917431,1.0,3/12,7.13%,NQO2;AIFM2;NDUFS7
prerank,P-type ion transporter activity (GO:0015662),0.6386581263346166,1.3977514700614073,0.09130434782608696,0.7589140457371307,1.0,3/12,8.60%,ATP2C1;ATP2A2;ATP2B1
prerank,cation:chloride symporter activity (GO:0015377),-0.5648438526600339,-1.3965438630829932,0.10526315789473684,1.0,1.0,6/10,27.28%,SLC12A7;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6
prerank,metallopeptidase activity (GO:0008237),0.47282678362348995,1.391656299975516,0.02354145342886387,0.7760055721384448,1.0,21/113,11.70%,ADAMTSL2;MMP12;MMP17;MMP11;MPND;ADAMTS7;NRDC;PRPF8;ADAMTS10;ADAMTS20;ANPEP;METAP1;THOP1;ADAMTS5;LAP3;ADAMTS6;ADAM33;METAP1D;AFG3L2;ADAM12;PAPPA
prerank,cadherin binding (GO:0045296),-0.27021762739164107,-1.3879807814215797,0.0,1.0,1.0,110/315,17.70%,NIBAN2;WASF2;COBLL1;PTPRB;CD2AP;CAST;DAB2IP;PICALM;EXOC3;CTNNA3;RDX;EGFR;CD46;EIF3E;PPME1;BAIAP2L1;DOCK9;YWHAZ;VAPA;EPS15L1;ITGA6;FLNA;MARK2;ARHGAP18;MB21D2;PARVA;MAPRE1;EIF2A;BSG;PTPRM;PDLIM5;BAG3;TJP1;SWAP70;STAT1;SLC3A2;PKP4;CEMIP2;CTTN;NOTCH3;UBAP2;CDH6;HSP90AB1;NCK1;TRIM25;ANLN;NUMB;EZR;ERC1;ARVCF;SNX2;EEF2;USP8;ACVR1;RPL6;RPL24;CDH1;IDH1;CNN2;F11R;PROM1;PLCB3;PACSIN2;LRRFIP1;EHD4;GLOD4;EPN2;CHMP5;RAB1A;PLEC;ARHGAP1;KDR;TBC1D10A;GIGYF2;RPL34;RARS1;VASP;PKM;SLK;EPS15;PTPRO;RANGAP1;TRPC4;FNBP1L;RPL15;RPS2;CDC42EP1;PTPRT;HCFC1;CHMP2B;GIPC1;PTPRJ;TLN1;TWF2;PFN1;ESYT2;SRC;PCBP1;DIAPH3;TAGLN2;ARFIP2;RPS26;ATIC;UBFD1;ALDOA;EIF5;TWF1;EEF1D;HSPA5;RPL7A
prerank,G protein-coupled receptor binding (GO:0001664),0.46173732573621434,1.3862892390255075,0.01524390243902439,0.7884029246258518,1.0,29/132,18.07%,S1PR2;WNT2B;WNT5A;SFRP1;DVL2;TUB;ADM;STUB1;PICK1;CXCL12;DVL1;ARRB1;WNT4;PTCH1;TAFA5;GPRC5B;SDCBP;GNAS;PSMC5;GRK3;ZNRF3;USP4;TULP3;GRK2;AGTR1;USP33;GNAQ;CCL25;PACRG
prerank,adrenergic receptor binding (GO:0031690),0.5949768533415238,1.3838190482046169,0.09236947791164658,0.7858867204814334,1.0,5/16,14.61%,APLP1;UCHL1;GNAS;MAGI2;GRK2
prerank,vitamin D receptor binding (GO:0042809),0.6121626742513332,1.382389715810301,0.11772853185595568,0.7789863769397597,1.0,7/14,16.84%,MED24;MED12;MED14;MED13;MED4;SNW1;THRAP3
prerank,NADP binding (GO:0050661),-0.38798409247061477,-1.3805752913350489,0.057803468208092484,1.0,1.0,21/32,39.25%,LBR;ME3;CAT;CRYZL1;NOS3;DECR1;DUS2;NOX1;MTRR;CBR4;NOS1;NNT;SPR;DHFR;KCNAB1;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5259540329760971,-1.3794787676084703,0.115625,0.9614988676137532,1.0,6/12,27.21%,SLC6A6;SLC3A2;SLC36A4;SLC38A5;SLC1A4;SLC36A1
prerank,voltage-gated cation channel activity (GO:0022843),0.46971211486128733,1.3789283409592854,0.03441084462982273,0.7828496929907189,1.0,19/97,15.43%,CACNA2D2;KCNG2;KCNA4;KCNC1;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;KCNMA1;KCNC2;GRIN2A;KCNQ4;CACNB1;KCND3;KCNH5;KCNA1;KCNQ2;CACNG4
prerank,poly-purine tract binding (GO:0070717),0.5539143674865651,1.377761612421318,0.10408921933085502,0.7744092592932201,1.0,12/27,16.79%,DDX3X;ATXN1;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL;FMR1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6324476359562184,1.3678651802064463,0.11958146487294469,0.8094874029689015,1.0,3/11,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.502341481509904,-1.367020903836508,0.12222222222222222,0.9647280647573225,1.0,7/13,19.11%,ERN1;PDGFC;IL1R1;PTPRJ;PDGFA;PDGFD;VEGFA
prerank,muscle alpha-actinin binding (GO:0051371),0.6093416070021602,1.366232644799085,0.12952646239554316,0.8041909682984252,1.0,2/15,1.71%,PDLIM2;PDLIM7
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5952567936520233,1.3624552061875679,0.11772853185595568,0.796345583695526,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.5952567936520233,1.3624552061875679,0.11772853185595568,0.796345583695526,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,deubiquitinase activity (GO:0101005),0.46008052500444674,1.3613568236657323,0.051362683438155136,0.7885908205259408,1.0,37/88,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;EIF3F;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,growth factor activity (GO:0008083),0.4708362705111784,1.3611016487444698,0.06407563025210083,0.7769901070693961,1.0,7/74,10.19%,FGF20;FGF9;NTF3;FGF10;NRG3;EGF;GDNF
prerank,exonuclease activity (GO:0004527),0.49685066540462697,1.3598628866676152,0.08022598870056497,0.7701457532281498,1.0,15/46,17.40%,EXOSC1;EXOSC3;APLF;EXOSC7;EXOSC2;EXOSC8;ENPP2;AEN;ENPP1;CPSF3;ISG20L2;MRE11;CNOT6;RAD50;REXO1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5502290388403943,1.3549088737244714,0.12082262210796915,0.7821697514166774,1.0,8/22,16.35%,ATP2C1;ATP6V0A2;ATP2A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,gated channel activity (GO:0022836),0.5968640552045497,1.353651824355762,0.11294765840220386,0.7764078394418213,1.0,2/14,3.55%,TMC5;TMEM63A
prerank,transcription corepressor binding (GO:0001222),0.532035694166588,1.3507618345838979,0.11851851851851852,0.7783458565556165,1.0,9/27,16.05%,HDAC3;RORA;PHF1;EZH2;EHMT2;PER1;USP11;EHMT1;CTBP1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6483061052528807,1.3486489031531421,0.13737075332348597,0.7772748062580969,1.0,3/10,16.34%,SLC6A11;SLC6A12;SLC6A13
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3728763846188125,-1.3437398138234429,0.08839779005524862,1.0,1.0,15/31,27.28%,SLC12A7;KCNK5;ABCC9;TMEM175;TMEM38A;SLC12A4;TMEM38B;SLC12A9;KCNA2;SLC12A2;KCNK9;SLC12A8;KCNK1;HCN1;SLC12A6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.45721610525112444,1.3388332553512192,0.07917570498915401,0.8123555679492726,1.0,12/75,12.14%,KCNAB2;PRXL2B;ADH5;RDH10;BDH1;RDH11;HADHB;HSD17B4;RDH5;MDH2;AKR1B10;EHHADH
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6097599904769352,1.338003032379769,0.14307004470938897,0.8039369026081322,1.0,3/12,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,neuropeptide binding (GO:0042923),0.5756365144103807,1.3365216723126427,0.13678618857901725,0.7991859377578904,1.0,4/18,17.95%,OPRK1;GPR37;GPR149;SORL1
prerank,syntaxin binding (GO:0019905),0.474052949796551,1.3329407460766722,0.09220636663007684,0.8046131028869766,1.0,19/61,16.55%,SYT3;SYT10;UNC13A;NAPG;STX6;ABL1;VAMP3;STX16;CPLX1;SNAP25;SCFD1;VPS54;SYT1;TMED10;DAPK1;STX8;VPS18;VAMP8;NSF
prerank,sodium channel regulator activity (GO:0017080),0.5093621774019526,1.3321783707042048,0.10380622837370242,0.797303524526195,1.0,13/37,21.46%,GPLD1;GPD1L;YWHAH;SCN2B;FGF12;CAMK2D;PTPN3;FGF14;SCN1B;ATP2B4;SGK3;FGF13;COMMD1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6176666150734205,1.329236820417501,0.13953488372093023,0.8005409965339544,1.0,5/11,19.43%,NTHL1;APLF;HMCES;ALKBH1;RPS3
prerank,FAD binding (GO:0071949),0.5293672412137997,1.3286196981009026,0.14010282776349614,0.7932054007463423,1.0,2/24,1.50%,CYB5R2;NQO2
prerank,retinoic acid binding (GO:0001972),0.5995102189321455,1.3283050928976825,0.14511494252873564,0.7839662809391944,1.0,2/12,12.85%,NR2F2;CYP26B1
prerank,phospholipase A2 activity (GO:0004623),0.5234736492135639,1.3274617258584687,0.13473423980222496,0.777719991583426,1.0,2/26,5.71%,PLA2G5;PRDX6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4749834595631969,-1.324801662477716,0.1736111111111111,1.0,1.0,9/14,41.54%,CYB5R4;NOX1;CYBA;MICAL1;NCF2;AIFM1;CYBB;KMO;NOX4
prerank,receptor antagonist activity (GO:0048019),0.5650272483817279,1.3145328234074367,0.13249651324965134,0.8260738656161276,1.0,3/17,14.59%,DKK3;LRPAP1;PXDN
prerank,cardiolipin binding (GO:1901612),0.629493348600033,1.3132085812092265,0.1554559043348281,0.821550400610167,1.0,2/10,2.84%,GSDMD;PLEKHN1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.47259038790251223,-1.311053477305904,0.1598639455782313,1.0,1.0,7/14,22.08%,MTMR12;MTMR10;MTMR3;MTMR14;MTMR9;MTMR11;MTMR6
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5055988129069553,1.3105877207518377,0.1455223880597015,0.8239029237955138,1.0,9/29,19.00%,CDKN2D;HEXIM1;PKIB;CIT;YWHAG;PKIG;SPRY2;PRKAR1A;PRKAG2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5923824806836315,1.3102595991515718,0.1678622668579627,0.8149746694419484,1.0,5/13,18.79%,ADH5;ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1
prerank,histone methyltransferase activity (GO:0042054),0.4946696595752152,1.3067771728000388,0.13513513513513514,0.8210293356191258,1.0,15/32,19.80%,PRMT6;FBL;SETD7;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;PRMT2;KMT5B;CARM1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4726455913370039,-1.3044816400335084,0.19202898550724637,1.0,1.0,8/13,22.72%,GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,E-box binding (GO:0070888),0.49250627724782736,1.3004869015735605,0.13598074608904934,0.8405130812022603,1.0,9/34,16.27%,CIART;SNAI1;TCF4;ZEB1;PER1;PRMT5;TWIST1;TCF3;CLOCK
prerank,ubiquitin-specific protease binding (GO:1990381),0.5512784756032598,1.3004001428075271,0.14456233421750664,0.8308493303110295,1.0,7/19,16.39%,SELENOS;SYVN1;CHMP3;VCP;SART3;PARK7;DERL1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4997523475428928,-1.2973058288777712,0.17073170731707318,1.0,1.0,5/11,22.53%,EGFR;TAOK2;MAP3K13;MAP3K4;MAP3K5
prerank,mRNA 3'-UTR binding (GO:0003730),0.44638975833771277,1.296163900562537,0.11170212765957446,0.8413070720778546,1.0,20/79,14.23%,ILF3;CPEB1;KHSRP;PCBP4;ZFP36L1;IGF2BP2;CELF2;EXOSC8;CELF1;RNF40;PABPC4;RBMS3;DHX36;PABPC1;RBMS1;NUDT21;RBMS2;HNRNPA0;CSDC2;HNRNPA2B1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4639568432738368,-1.2957231486405405,0.16206896551724137,1.0,1.0,6/15,10.99%,PICALM;WDFY3;EPB41;SCARB1;ZFYVE9;ZFYVE1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4545864122614574,-1.2949673331283589,0.16605166051660517,0.9945835510999194,1.0,6/16,12.17%,INPP5F;MTMR12;MTMR10;MTMR3;MTMR14;MTMR9
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5080237258244644,-1.2903486431660551,0.18618618618618618,0.9784732230686524,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,carbohydrate kinase activity (GO:0019200),0.6091736362516889,1.2885553791513091,0.19416058394160585,0.8667000290185579,1.0,2/11,2.71%,XYLB;GALK1
prerank,snRNA binding (GO:0017069),0.47176935258148717,1.2864029902326728,0.1471264367816092,0.8666906706779026,1.0,15/42,21.20%,HEXIM1;LSM7;COIL;TOE1;PRPF8;CDK9;SNRPB2;SART3;RBM41;CCNT1;RBM22;HNRNPU;GEMIN5;CCNT2;RBM7
prerank,intracellular chloride channel activity (GO:0061778),-0.43585468645278796,-1.280879408758001,0.1556420233463035,0.9487763838895868,1.0,10/16,36.93%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.43585468645278796,-1.280879408758001,0.1556420233463035,0.9487763838895868,1.0,10/16,36.93%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,NF-kappaB binding (GO:0051059),0.5113543418096442,1.2781596132992663,0.16944801026957637,0.8960875822060729,1.0,8/24,17.72%,HDAC3;COMMD6;CDK5RAP3;NPM1;HDAC1;FAF1;MTDH;ANXA4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5064874036870158,1.275485828009421,0.16646115906288533,0.8986623256348999,1.0,4/26,9.21%,B3GALNT1;CHPF;CHSY3;EXTL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5281817017871732,1.274619911045715,0.19129287598944592,0.8926925184228329,1.0,9/20,19.20%,OTULINL;USP7;USP47;UFSP2;SENP5;USP9X;EIF3F;USP50;YOD1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5345178088371259,1.2736744618480333,0.20159151193633953,0.8870636215999235,1.0,6/20,14.26%,MOGAT3;AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5216206374098136,1.2707970529050778,0.1761006289308176,0.8907751274198487,1.0,15/23,26.25%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1;HNRNPU;PTBP1;U2AF2;KHDRBS1;PNPT1;HNRNPH1;HNRNPC
prerank,chloride channel inhibitor activity (GO:0019869),0.6020515202661324,1.2623699241584787,0.20516717325227962,0.9206757553021249,1.0,7/10,26.38%,WNK2;VTI1B;STX8;VAMP8;WNK3;STX7;STX1A
prerank,acylglycerol lipase activity (GO:0047372),-0.4910645544865955,-1.2572599382150182,0.19938650306748465,1.0,1.0,3/11,7.16%,MGLL;ABHD6;ABHD2
prerank,voltage-gated potassium channel activity (GO:0005249),0.43070189771281225,1.2552367012488563,0.14331210191082802,0.9458523697659547,1.0,13/80,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;KCNMA1;KCNC2;KCNJ10;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.539643672573794,1.2537928275483323,0.20885200553250347,0.9426290636682493,1.0,3/17,5.66%,THEM4;ACOT9;ACOT11
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.4661045440422701,-1.2502640266834752,0.21656050955414013,1.0,1.0,7/12,25.44%,DAB2IP;VEGFC;CADM4;VEGFA;VEGFB;PGF;ITGB3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4443376280845114,-1.2502124789675182,0.18118466898954705,0.9819718962322421,1.0,9/14,27.23%,CASP8AP2;BCL2L13;NOD1;EBAG9;MAL;APAF1;BAD;ATP2A3;RPS27L
prerank,MAP-kinase scaffold activity (GO:0005078),0.5859640338324266,1.2501639922225578,0.20974889217134415,0.9501863325261015,1.0,6/11,19.10%,MAPK8IP1;IQGAP1;MAPK8IP3;AKAP13;MAP2K2;KSR1
prerank,outward rectifier potassium channel activity (GO:0015271),0.5773628755758534,1.2485921294888838,0.22660818713450293,0.9474828760842854,1.0,4/11,18.02%,KCNK2;KCNT2;KCND3;PKD2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5698026114914122,1.2467068245895718,0.2297872340425532,0.9469605788124091,1.0,7/12,22.48%,POU2F1;TBP;HDAC1;TBPL1;H3-3A;TAF1;GTF2B
prerank,nucleotidase activity (GO:0008252),-0.45763220693200657,-1.2442481207346086,0.18661971830985916,0.9777079004997474,1.0,4/15,9.08%,NT5C2;BPNT2;NT5E;NT5M
prerank,hexose transmembrane transporter activity (GO:0015149),0.5732074461790331,1.2436504526791168,0.23842917251051893,0.9512875193540528,1.0,3/12,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4486666262562956,1.2425673194638691,0.15427302996670367,0.946932083771197,1.0,12/54,13.47%,HDAC3;GLS2;SIRT2;SIRT7;MIER2;NGLY1;HDAC5;ASRGL1;HDAC4;NTAN1;HDAC1;NIT1
prerank,retinoid binding (GO:0005501),0.5025882590113864,1.2420248779167278,0.2064935064935065,0.9400585743365916,1.0,4/22,12.85%,NR2F2;ALDH1A2;RBP1;CYP26B1
prerank,G protein-coupled receptor activity (GO:0004930),0.40648926919993233,1.2408257481241365,0.04609218436873747,0.9361789139723816,1.0,29/239,14.70%,FSHR;S1PR2;MRGPRF;LTB4R2;MRGPRE;VIPR2;OPRK1;GPR22;GPR63;CXCR4;HCRTR2;ADGRV1;GPR37;BDKRB2;GPR149;GPR4;TPRA1;GPR45;ELOVL4;LGR4;PTH1R;HCRTR1;ADGRG1;LANCL1;GPR161;GABBR1;LPAR1;LPAR6;PDGFRL
prerank,kinesin binding (GO:0019894),0.48197664370363397,1.2386681900531633,0.21033210332103322,0.9374743390726791,1.0,7/27,12.38%,SPTBN5;ARHGEF10;MAPK8IP1;NEFH;TOR1B;PLEKHM2;MAPK8IP3
prerank,endopeptidase activity (GO:0004175),0.40714676167561464,1.235008169446409,0.048,0.9449768867977439,1.0,53/257,17.62%,ADAMTSL2;MMP12;MMP17;SFRP1;MMP11;ADAMTS7;RHBDL3;USP14;NRDC;USP7;USP30;UCHL1;CASP7;ADAMTS10;PCSK5;USP1;USP38;ADAMTS20;PCSK2;USP24;USP47;THOP1;PSMB10;USP42;HTRA3;ADAMTS5;ADAMTS6;USP10;PLAT;MBTPS1;CASP9;ADAM33;USP2;MALT1;AFG3L2;USP11;USP15;PRSS12;USP40;USP9X;ADAMTS3;CTSZ;F3;RHBDF1;CASP2;USP34;USP35;CTSH;USP48;ADAMTS1;PARL;USP33;OMA1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5118377940990964,1.2299587862990515,0.22074468085106383,0.9593274820596521,1.0,8/20,18.75%,CASK;AK4;AK3;AK6;MAGI3;DLG2;CMPK1;MPP1
prerank,ankyrin binding (GO:0030506),-0.39757973454291556,-1.2292985431386645,0.16597510373443983,1.0,1.0,6/19,17.94%,CACNA1D;CDH1;PLEC;PTPRC;SPTB;KCTD6
prerank,hexosaminidase activity (GO:0015929),-0.46741644178060826,-1.2292528849545659,0.23745819397993312,0.9817347569046149,1.0,5/12,26.04%,OGA;CEMIP2;HEXD;HYAL1;NAGA
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4903549578800954,1.2292288861289535,0.2089171974522293,0.9535646475575688,1.0,10/25,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,poly(U) RNA binding (GO:0008266),0.5225693051933404,1.2273467265284117,0.2214941022280472,0.9532945425958216,1.0,8/20,16.79%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5228483455800731,1.225742815852187,0.2163978494623656,0.9515756427643834,1.0,10/17,24.55%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5528498200801092,1.2256560442420372,0.23959827833572453,0.9431205141946216,1.0,5/13,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3513249634190625,-1.2252259281919944,0.18556701030927836,0.9703520691785052,1.0,14/29,38.22%,SLC26A7;SLC25A13;SLC26A2;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6;SLC26A8
prerank,pentosyltransferase activity (GO:0016763),0.45972021545360825,1.2239428596379494,0.20284697508896798,0.9421283111536813,1.0,13/36,18.69%,SIRT2;PARP1;PARP2;UPP2;PARP14;PARP16;LACC1;SIRT5;ZC3HAV1;TNKS;TIPARP;QTRT2;PARP11
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4379147716604909,1.2235635745345421,0.19730941704035873,0.9353610672552888,1.0,12/49,15.68%,DUSP28;DUSP18;SMPDL3B;GDPD3;ATP1A2;PRUNE1;PPP1CC;HDHD2;PTPN22;EPHX2;PPP5C;SACM1L
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.48177981457108476,1.2214123249659623,0.21929824561403508,0.9369049678334647,1.0,6/25,12.91%,CYP27A1;POR;MSMO1;CYP26B1;FMO4;FMO2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5696800100894385,1.2210166324233314,0.22046109510086456,0.9302633690329917,1.0,3/11,19.36%,SLC22A4;SLC25A20;SLC25A47
prerank,protein kinase C binding (GO:0005080),0.44574975797358174,1.2199692729674996,0.20069605568445475,0.9268409259212075,1.0,16/43,23.20%,DACT2;PICK1;NELL1;TIRAP;ABL1;SQSTM1;HDAC5;YWHAG;RACK1;PRKD2;CCDC88A;ITGAV;TOP2B;PARD6G;PKN1;HINT1
prerank,kinase inhibitor activity (GO:0019210),0.4735199588329646,1.2187303887760168,0.20073891625615764,0.9237662367328765,1.0,7/33,8.79%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;WARS1;MAPK8IP1;SH3BP5L
prerank,flavin adenine dinucleotide binding (GO:0050660),0.43626604509592054,1.2155487704364627,0.2034090909090909,0.9292687018554945,1.0,6/53,6.76%,CYB5R2;GFER;NQO2;AIFM2;SDHA;POR
prerank,calcium ion binding (GO:0005509),0.3954031175559241,1.215341666066285,0.048,0.9221868022140702,1.0,75/323,21.79%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;RASGRP2;SPARC;ADGRV1;RCN3;SPOCK1;CRACR2A;CDH11;PITPNM3;ENPP2;MCTP2;BNIP2;IQGAP1;ENPP1;FBN1;SYT1;SPOCK2;PAM;LRP1;CDH18;SLIT1;SLIT3;EFHD1;ANXA2;MAN1C1;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SCUBE1;CALM1;TPM4;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;GSN;SYT11;SYT12;CDH10;SDF4;CALM2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4287281861564525,1.2150879494507603,0.2045701849836779,0.9154742563864317,1.0,15/60,13.11%,MST1R;EPHA7;EPHB2;FGFRL1;FGFR2;FGFR1;DDR1;NRP1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;IGF2R;ROR2
prerank,chloride channel regulator activity (GO:0017081),0.5400134518961449,1.2124694249564938,0.2514367816091954,0.9195411336092039,1.0,9/14,26.38%,WNK2;VTI1B;STX8;VAMP8;SGK3;WNK3;SGK1;STX7;STX1A
prerank,potassium channel regulator activity (GO:0015459),0.4410927569069984,1.2124613628560283,0.2135593220338983,0.9118375219661854,1.0,3/49,4.12%,AMIGO1;KCNAB2;SLC5A3
prerank,alkali metal ion binding (GO:0031420),0.5554845610024242,1.212277099707573,0.24645892351274787,0.9051057082775527,1.0,4/13,9.36%,ACAT1;ATP1A2;DRG1;HDAC4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5767736059033698,1.2093809564717781,0.2303120356612184,0.910202986991985,1.0,3/10,12.26%,SIRPA;JUP;CD47
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.47598523879108356,-1.2085681075624242,0.22418879056047197,1.0,1.0,8/10,32.98%,PML;DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,copper ion binding (GO:0005507),0.44187997359931697,1.2041244596420353,0.21149425287356322,0.9254020796273543,1.0,12/42,21.53%,GPC1;CUTA;COX17;PARK7;SOD3;PAM;LACC1;HEPH;MOXD1;S100A13;COMMD1;ATOX1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3733039942829619,-1.2032088176747886,0.19069767441860466,1.0,1.0,8/23,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.34807947961578706,-1.2026096228626575,0.2111801242236025,0.9816442565052818,1.0,20/33,30.24%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RRN3;RPRD1B;SCAF8;PAF1;SMYD2;SPTY2D1;CCAR2;ERBB2;SUPT4H1;CTR9;ELP4;MAF1;DHX9;RPRD1A
prerank,tubulin binding (GO:0015631),0.38859813160338436,1.1995648164754598,0.07522567703109329,0.9373903078648239,1.0,83/296,20.19%,PSRC1;CFAP157;FSD1;B9D2;ARL4C;CCDC61;CCDC170;CENPJ;REEP4;STMN4;DNM1;WHAMM;MAPRE3;TTLL4;TAOK1;KIF3A;DDX3X;DIP2B;MDM1;RAE1;NEFH;ALMS1;CDK5;TBCA;MTCL1;ARHGEF7;KIF3C;MACO1;TPPP3;GAS2L1;VBP1;RMDN2;PRUNE1;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;BRSK1;TPGS1;DIXDC1;KIF5C;DAG1;BLOC1S2;GIT1;HTT;RABGAP1;MAPT;UNC5C;MAP1LC3B;EML2;DNM1L;OFD1;VAPB;TBCD;TTLL11;AGBL4;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;PACRG;CCDC88A;EML3;ARL8B;PDCD5;KIF20B;KRIT1;MAP6D1;AGTPBP1;RPS3;DNAL1;DLEC1;PAFAH1B1;INO80;KIF6;DCX
prerank,methyltransferase activity (GO:0008168),0.4371140355290837,1.1986316136378636,0.21305841924398625,0.9339419273201179,1.0,12/46,13.05%,COMTD1;LCMT1;MGMT;BUD23;NNMT;PRMT5;NTMT1;SUV39H1;CARNMT1;COMT;PRMT1;EHMT1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.43489063542659556,-1.1985317064195684,0.254601226993865,0.9726374305126622,1.0,9/13,28.90%,TRMT1L;THUMPD3;THUMPD2;TARBP1;FTSJ1;TRMT10B;METTL1;TRMT10A;TRMT5
prerank,O-acyltransferase activity (GO:0008374),0.4688308171961354,1.1980066232353739,0.24004825090470447,0.9291168075702837,1.0,5/30,9.52%,MOGAT3;PRDX6;GPAT4;SOAT1;GPAM
prerank,metalloexopeptidase activity (GO:0008235),0.4308536601882606,1.1977817750195052,0.22635135135135134,0.9227022929694904,1.0,16/51,20.34%,MMP17;XPNPEP3;CPXM1;ANPEP;METAP1;LAP3;AGBL3;PEPD;METAP1D;CPXM2;METAP2;AGBL4;DPEP1;AGTPBP1;MMP14;MMP16
prerank,retinoic acid receptor binding (GO:0042974),-0.4012539494279283,-1.1954052170121332,0.20816326530612245,0.9611473508187831,1.0,9/17,23.38%,CNOT1;NCOA6;MED1;RARG;ASXL1;MED25;NRIP1;PPARG;NR4A2
prerank,phosphatase activator activity (GO:0019211),0.5296733485303668,1.1951296099987816,0.2541208791208791,0.9264978412844831,1.0,8/14,24.08%,CALM3;FRS2;PPP2R5E;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,NADPH binding (GO:0070402),-0.43067076474495325,-1.1948218315383388,0.2347266881028939,0.9402923615400454,1.0,11/13,41.92%,LBR;DECR1;DUS2;MTRR;CBR4;DHFR;KCNAB1;NDOR1;CRYZ;CBR3;GRHPR
prerank,protein phosphatase activator activity (GO:0072542),0.5420928713960249,1.1938933945527237,0.24826629680998613,0.9241208663050854,1.0,8/13,24.08%,CALM3;PPP2R5E;IGFBP3;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.31522098927942527,-1.1925813322578611,0.1830065359477124,0.9269287673987674,1.0,11/34,16.08%,GBF1;PARD3;MYO10;FERMT2;ARAP2;PLEKHB2;ZFYVE1;DAPP1;IQGAP2;ARAP3;KIF16B
prerank,acetyltransferase activity (GO:0016407),-0.33648348050803023,-1.1912869204763545,0.17543859649122806,0.9108877533831209,1.0,11/31,20.27%,SMARCE1;ELP3;NAA15;KAT2B;SAT1;EP300;PAFAH1B2;NAT10;KAT6B;KAT8;NAA80
prerank,phospholipase inhibitor activity (GO:0004859),0.566282710995973,1.1911799227886202,0.2768777614138439,0.928870861831433,1.0,3/10,17.72%,ANXA1;ANXA2;ANXA4
prerank,four-way junction DNA binding (GO:0000400),0.4966601125161963,1.1901731213297317,0.27808219178082194,0.9258273861332784,1.0,5/17,11.61%,XRCC2;HMGB3;ABL1;FANCM;YY1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4750665074481212,1.1898562924027063,0.26727509778357234,0.9201263309851653,1.0,10/24,22.38%,CAMK2B;CAMK1G;CAMK2D;CAMK2G;DAPK1;CAMK1D;PHKA2;PTK2B;MAPKAPK2;EEF2K
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5086748241889792,1.1875349852701256,0.26264044943820225,0.9225765328096198,1.0,1/16,0.55%,HGD
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.31905456914030994,-1.1845167783608792,0.19285714285714287,0.9156269302038296,1.0,11/38,17.58%,PARD3;DAB2IP;DENND1A;ATG2B;ZFYVE26;TECPR1;ZFYVE1;HIP1;BBS5;KIF16B;ZFYVE19
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44805517215380875,-1.1837354631702313,0.22955974842767296,0.8983537878991327,1.0,6/12,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;LTBP4;BMPR1B
prerank,double-stranded RNA binding (GO:0003725),0.4111988630552834,1.1817220477939465,0.2158351409978308,0.9394200671588562,1.0,20/70,17.09%,ILF3;APTX;TARBP2;DGCR8;PRKRIP1;DDX3X;DHX15;DHX30;DHX58;DHX33;DHX36;RC3H2;AGO3;TLR3;SIDT1;TUBA1B;HSPD1;FMR1;OAS2;MTDH
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.45566795254347947,1.1793641178210703,0.2541966426858513,0.942039385861501,1.0,8/33,15.43%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;XRN1;DIS3L2;CNOT6
prerank,aminopeptidase activity (GO:0004177),0.47222592990130957,1.1778935649057292,0.27040816326530615,0.9411282749308387,1.0,8/26,15.68%,MMP17;XPNPEP3;ANPEP;METAP1;LAP3;METAP1D;METAP2;CTSH
prerank,cytokine receptor activity (GO:0004896),0.40418736560841206,1.1758470696142436,0.2364217252396166,0.9425388999701185,1.0,14/83,16.37%,IL10RA;IFNAR1;IL10RB;CCR9;ACKR2;IL31RA;IFNGR2;PRLR;GFRA2;LEPR;IFNGR1;F3;IL15RA;IL1RAP
prerank,fibroblast growth factor binding (GO:0017134),0.48869023848749055,1.1754585487944458,0.2630890052356021,0.9372870365772019,1.0,5/21,9.70%,FGFRL1;FGFR2;FGFR1;GPC1;KL
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.5292646616800687,1.1753427871928512,0.26564673157162727,0.930970450240412,1.0,8/13,24.60%,PIP4K2B;PIK3CB;PIP4K2A;PIP4K2C;PIK3C2B;PIP5K1A;PIKFYVE;PIK3C2A
prerank,calcium activated cation channel activity (GO:0005227),0.4982935117123568,1.1728310457934201,0.26851851851851855,0.9349856079485657,1.0,3/17,6.83%,TMEM63A;TMEM63C;KCNMA1
prerank,ribonuclease activity (GO:0004540),0.4237575438840385,1.1682861428376112,0.22494432071269488,0.9465407397898367,1.0,15/56,17.10%,EXOSC1;EXOSC3;EXOSC7;RNASE1;EXOSC2;RNASE7;LACTB2;EXOSC8;RCL1;CPSF3;AGO3;SND1;DIS3L2;CNOT6;ZC3H12C
prerank,ligand-gated anion channel activity (GO:0099095),-0.3848092509520259,-1.1665885938665435,0.2283464566929134,0.9437136136044051,1.0,9/17,22.72%,GABRB1;GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,thyroid hormone receptor binding (GO:0046966),0.45547425440929423,1.166564220760228,0.2731707317073171,0.9469125479330472,1.0,14/28,22.51%,MED24;MED12;MED13;TACC1;GAS2L1;MED4;BRD8;THRAP3;NSD1;PRMT2;NCOA3;TRIP12;GTF2B;MED17
prerank,chloride transmembrane transporter activity (GO:0015108),-0.39696110337333623,-1.1655740569077553,0.24912280701754386,0.9277846407247272,1.0,3/16,6.46%,SLC26A7;SLC26A2;CLCN6
prerank,mRNA 5'-UTR binding (GO:0048027),0.4671983594479418,1.1647422846441522,0.28877679697351827,0.9472593211158606,1.0,5/24,10.48%,GNL3;DDX3X;IGF2BP2;DHX36;MYH10
prerank,signal sequence binding (GO:0005048),0.44696101514752595,1.162726544740826,0.27001194743130225,0.9485711266488467,1.0,15/35,20.70%,KDELR3;KPNA3;SEC61A2;BRAP;TOMM20;KPNB1;PEX5;NUP214;TNPO1;CEMIP;NUP153;KPNA1;TIMM22;CABP1;PEX5L
prerank,pseudouridine synthase activity (GO:0009982),0.5277859869365896,1.162682207496971,0.31347517730496455,0.9421725519142718,1.0,3/13,9.92%,TRUB2;PUS10;PUS7
prerank,voltage-gated calcium channel activity (GO:0005245),0.44117532204514626,1.1614224425455217,0.2744405182567727,0.9407610882156348,1.0,6/37,10.31%,CACNA2D2;CACNG3;CACNB4;CACNA2D3;CATSPER3;CACNB1
prerank,acetylation-dependent protein binding (GO:0140033),0.47856099026284776,1.1597945373327514,0.2840466926070039,0.9346170539223777,1.0,9/20,22.18%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,lysine-acetylated histone binding (GO:0070577),0.47856099026284776,1.1597945373327514,0.2840466926070039,0.9346170539223777,1.0,9/20,22.18%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,actin binding (GO:0003779),0.37903383176900834,1.1591336094298292,0.19817073170731708,0.9309994483470982,1.0,32/170,13.93%,FHL3;PDLIM2;TNNI3;SPTBN5;LCP1;PDLIM7;ABITRAM;MYO19;VPS16;CGN;BCL7B;ARPC1A;MRTFA;ABL1;DMTN;DBN1;KCNMA1;CXCR4;GC;PHACTR3;SSH1;DBNL;PLEKHH2;MYH10;CAPZA1;TPM1;MOBP;FLNB;DAG1;ADD2;TLN2;MAPT
prerank,protein kinase C activity (GO:0004697),-0.408933821513528,-1.1587637649516185,0.26071428571428573,0.9321702739156195,1.0,4/14,4.51%,PRKCH;PRKCE;PRKCD;PRKD1
prerank,steroid hydroxylase activity (GO:0008395),0.4980717812293768,1.1586771966117837,0.29014084507042254,0.9266379407004782,1.0,2/16,6.56%,CYP27A1;CYP7B1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.43837616437751253,1.1561325300433436,0.26618705035971224,0.930387536906967,1.0,8/38,16.65%,SERPING1;SPOCK1;APP;TFPI;SERPINA2;SERPINE1;SERPIND1;ANXA2
prerank,monocarboxylic acid binding (GO:0033293),0.4739841939973408,1.1493599785936617,0.29683377308707126,0.9516320193677853,1.0,3/18,13.84%,NR2F2;CYP26B1;PSAP
prerank,acid-thiol ligase activity (GO:0016878),-0.4233102873662623,-1.1485562724018041,0.2983606557377049,0.9513032736256948,1.0,4/13,26.05%,AASDH;AACS;ACSS1;ACSS2
prerank,calcium channel activity (GO:0005262),0.39669799735220906,1.1483461163531083,0.2569593147751606,0.949347860288731,1.0,11/84,10.31%,CACNA2D2;PKD2L2;SLC24A5;ORAI2;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;SLC24A4;CACNB1
prerank,phospholipase C activity (GO:0004629),-0.3527949080618724,-1.1480386851047792,0.2562814070351759,0.9344184863568652,1.0,8/25,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,RNA cap binding (GO:0000339),-0.40098986870891423,-1.1479927644185335,0.3018181818181818,0.9165439255000714,1.0,7/16,11.40%,NCBP3;AGO2;DCPS;EIF4E;NCBP1;LSM1;SNUPN
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3778802761537881,1.1466781460577256,0.17853560682046138,0.9499294073537893,1.0,67/232,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;PIAS3;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;PIAS1;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,chemokine binding (GO:0019956),0.4468041987288524,1.14477519728848,0.29040097205346294,0.9512823034948877,1.0,7/30,22.00%,CCR9;ACKR2;CXCR4;ITGAV;ITGB1;FGF2;HMGB1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5044736467814451,1.1427503945745603,0.3319268635724332,0.9535548589415872,1.0,5/15,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,GTPase binding (GO:0051020),0.37117557645873783,1.1419762185089817,0.18611670020120724,0.9504639262758796,1.0,65/195,21.18%,UNC13D;CDC42EP5;LCP1;CDC42EP4;MTSS2;TSC2;RAB11FIP4;HSP90AA1;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;ATG14;TRIP11;GNB2;MYCBP2;RAP1GAP;CYFIP1;EPRS1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;RADIL;STK19;RNF41;DNM1L;SPTBN1;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;AMBRA1;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;YBX1;RUSC2;RAB11FIP3;MAPKAP1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5313173256880612,1.1417600251023856,0.31419939577039274,0.9451979096496659,1.0,7/10,26.13%,PKIB;PKIG;PRKAR1A;PRKAG2;PKIA;PRKAR1B;PRKAR2A
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4344997415217284,1.134120336594109,0.32461355529131986,0.9693516352116432,1.0,5/34,5.02%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1
prerank,protein kinase inhibitor activity (GO:0004860),0.41982191795152446,1.1339357555583989,0.295662100456621,0.9640035981084902,1.0,9/42,12.69%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;MAPK8IP1;CIT;SH3BP5L;NPM1;RACK1
prerank,small GTPase binding (GO:0031267),0.36921194403916374,1.131844503813524,0.22975708502024292,0.9659440618753324,1.0,56/170,21.18%,UNC13D;CDC42EP5;CDC42EP4;MTSS2;TSC2;RAB11FIP4;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;TRIP11;MYCBP2;RAP1GAP;CYFIP1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;STK19;RNF41;DNM1L;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;RUSC2;RAB11FIP3;MAPKAP1
prerank,adenylate cyclase binding (GO:0008179),0.5421495978045259,1.1314861678600059,0.33627019089574156,0.9614577643966076,1.0,5/10,21.79%,CALM3;AKAP12;ADCY5;CALM1;CALM2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4210240559471514,1.1304092409362962,0.30320366132723114,0.9596415227235525,1.0,10/40,12.90%,COMTD1;LCMT1;FBL;DPH5;NNMT;SUV39H1;CARNMT1;COMT;METTL2B;METTL2A
prerank,ligand-gated calcium channel activity (GO:0099604),0.46957927694991536,1.1299566904181952,0.32938076416337286,0.9554789048479523,1.0,3/19,8.22%,GRIN1;ITPR1;GRIN2A
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4108833527575319,1.1294919572129871,0.29365079365079366,0.9512641964065665,1.0,17/49,23.24%,SYT3;SYT10;ANXA1;RPH3A;CPNE7;MCTP2;SYT1;CPNE8;ANXA2;ANXA4;MCTP1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.43777977880347796,-1.1277521665561632,0.30959752321981426,0.9702937988742177,1.0,5/11,20.27%,NAA15;NAA40;NAA25;NAA60;NAA80
prerank,ubiquitin protein ligase activity (GO:0061630),0.3714374656984442,1.1271610600002433,0.20962888665997995,0.9545293496871557,1.0,65/228,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4002128973600068,1.1266246844223162,0.28833693304535635,0.950845344369648,1.0,8/70,9.03%,B3GALNT1;B3GLCT;CHPF;OGT;MGAT4B;POMGNT1;CHSY3;MGAT4C
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3990888937475414,1.1239212186131875,0.311731843575419,0.9554206556902151,1.0,8/55,8.64%,PKD2L2;SLC24A5;ATP2C1;GRIN1;ATP2A2;ITPR1;ATP2B1;SLC24A4
prerank,glucose transmembrane transporter activity (GO:0005355),0.4880168273221724,1.1235907957261673,0.3279569892473118,0.9509886940893837,1.0,3/17,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4912051611086842,1.123239980507682,0.31622746185852985,0.9411787036148062,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4912051611086842,1.123239980507682,0.31622746185852985,0.9411787036148062,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,5'-nucleotidase activity (GO:0008253),-0.42417493864581557,-1.118889016735962,0.31329113924050633,0.9857479468350376,1.0,3/13,9.08%,NT5C2;NT5E;NT5M
prerank,potassium channel activity (GO:0005267),0.3819486639758223,1.1184947568742702,0.3036649214659686,0.9533155328368114,1.0,13/89,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;GRIK5;KCNMA1;KCNC2;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,nuclear receptor coactivator activity (GO:0030374),0.3972447651355052,1.1181782555655437,0.3329646017699115,0.9489988791967748,1.0,21/52,22.79%,MED24;MED12;MED14;MED13;TACC1;MED4;SLC30A9;SRA1;CALCOCO1;BRD8;CNOT9;ZMIZ1;CNOT6;THRAP3;USP22;NCOA3;CARM1;FGF2;PKN1;MED17;NCOA1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.436884093380291,-1.1175920271259094,0.3627450980392157,0.9732382503228705,1.0,2/11,0.69%,MBD2;LEF1
prerank,GDP binding (GO:0019003),-0.2701242146069811,-1.1171393059039247,0.21296296296296297,0.9574472778611135,1.0,17/63,12.41%,RAB2A;KRAS;RAB18;RAB14;NRAS;RRAGC;RHEB;RAB5C;RALB;RAB27A;ARL3;RAB22A;RAB9A;RIT1;RASL12;GNAI3;MIEF1
prerank,ubiquitin binding (GO:0043130),0.3874323218717689,1.1149839477784278,0.3034188034188034,0.955435835860581,1.0,15/73,9.10%,OTULINL;MVB12A;SIRT2;UBXN2A;USPL1;UCHL1;RAE1;TNFAIP3;FBXO7;UBXN7;SQSTM1;UCHL3;CXCR4;RNF168;AUP1
prerank,damaged DNA binding (GO:0003684),0.406545444873011,1.1128096403947498,0.3314020857473928,0.9583896410283003,1.0,8/44,10.65%,APTX;NTHL1;MPG;SDE2;DDB1;FANCG;CUL4B;DCLRE1A
prerank,GABA-A receptor activity (GO:0004890),-0.36816773498389926,-1.1116127132755727,0.2868217054263566,0.9601551748426038,1.0,6/18,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4177733956059962,1.111489956446368,0.33412042502951594,0.9577432925599222,1.0,8/35,13.94%,SMPDL3B;GPLD1;SMPD2;GDPD3;ENPP2;ENPP1;TDP2;SMPD4
prerank,metalloaminopeptidase activity (GO:0070006),0.4770599390694034,1.1104575480357988,0.3457814661134163,0.9562896369571489,1.0,3/16,5.45%,MMP17;XPNPEP3;ANPEP
prerank,histone deacetylase binding (GO:0042826),0.3816764642162673,1.10800020301781,0.3154008438818565,0.960030369990239,1.0,16/88,12.36%,CAMTA2;HDAC3;SIRT2;HSP90AA1;USF1;MIER2;NIPBL;RBBP4;AKAP8L;HDAC5;DHX36;HDAC4;NUDT21;NACC2;MTA2;HDAC1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3141783253922596,-1.1011354632882553,0.27439024390243905,0.9805328959979552,1.0,11/33,13.99%,PCF11;WAC;ERCC5;AR;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4099189400024405,-1.100535753107192,0.31921824104234525,0.9659865369918658,1.0,6/12,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5198041597651608,1.099322853106523,0.3726346433770015,0.9870780026131853,1.0,4/10,14.75%,HADHB;HSD17B4;EHHADH;ECHDC1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.39790816624509057,1.0975350037995066,0.35714285714285715,0.9885212942403361,1.0,10/49,9.82%,UBQLN1;PSMD4;PRPF8;TNFAIP3;OTUD7A;SQSTM1;ZFAND6;RNF168;ABRAXAS2;VCP
prerank,ion channel activity (GO:0005216),0.37393809205336925,1.0974990682952879,0.33544303797468356,0.9831596642765013,1.0,9/80,8.77%,TMC5;NALCN;LRRC8A;TMEM63A;GRIN1;GRIK5;CALHM2;GRIN2A;TRPM3
prerank,DNA replication origin binding (GO:0003688),-0.34031176220548276,-1.0973284002068648,0.2922374429223744,0.9614988676137535,1.0,19/23,50.34%,KAT7;ORC4;ORC5;MCM6;MCM4;DDX11;DHX9;ORC1;MCMDC2;MCM8;CDC45;MCM3;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,calcium channel regulator activity (GO:0005246),0.41550674242345587,1.0945824763003447,0.3534994068801898,0.9892372845550581,1.0,14/37,25.76%,TNNI3;ITPR1;PACSIN3;STIMATE;SLC30A1;CACNG4;CALM1;SGK3;CALM2;FKBP1A;SGK1;NRXN2;STIM2;STIM1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.48636757064012576,1.0941997928978893,0.35714285714285715,0.9852951217206936,1.0,4/14,15.38%,AASS;BLVRB;ALDH4A1;QDPR
prerank,lipid phosphatase activity (GO:0042577),0.4852231904805141,1.093482321788376,0.3952513966480447,0.9825738387364342,1.0,4/14,14.72%,PLPPR2;PLPP3;PLPPR5;EPHX2
prerank,glutathione transferase activity (GO:0004364),0.4428288844462452,1.093055503860656,0.37548387096774194,0.9787922282279793,1.0,2/23,4.08%,ALOX5AP;GSTT1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3756818289495689,-1.090433458292979,0.32608695652173914,0.9694306341700502,1.0,7/18,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;ACVR2B;LTBP4;BMPR1B
prerank,fatty acid synthase activity (GO:0004312),0.5212810144108295,1.090089265111699,0.39020771513353114,0.9844986426761262,1.0,3/10,19.11%,ELOVL1;ELOVL4;ELOVL6
prerank,3'-5' exonuclease activity (GO:0008408),0.4010499358083015,1.0875342081286485,0.35894495412844035,0.9891310079257423,1.0,6/45,5.02%,EXOSC3;TOE1;APLF;EXOSC7;EXOSC2;USB1
prerank,phospholipase activator activity (GO:0016004),0.5085000662738475,1.0867131124311282,0.378125,0.9867080098574835,1.0,1/10,2.08%,PDPK1
prerank,exopeptidase activity (GO:0008238),0.39524144426795865,1.085918644822712,0.36806342015855037,0.9844354048577705,1.0,13/50,16.81%,XPNPEP3;DPP9;ANPEP;METAP1;LAP3;METAP1D;CNDP2;GGH;METAP2;DPP10;CTSZ;CTSH;DPEP1
prerank,phosphatidylglycerol binding (GO:1901611),0.4879698608106923,1.0850348270513452,0.386013986013986,0.9823603885937691,1.0,2/13,2.84%,GSDMD;PLEKHN1
prerank,lipase activator activity (GO:0060229),0.5048069080632294,1.0849720092768478,0.38425925925925924,0.9773824261546971,1.0,1/10,2.08%,PDPK1
prerank,transforming growth factor beta binding (GO:0050431),-0.3500619351329093,-1.0847461249081851,0.3333333333333333,0.9731614497200581,1.0,10/23,21.27%,TWSG1;ACVR1;THBS1;ENG;TGFBR2;LTBP4;CD109;NRROS;TGFB3;LRRC32
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.3832846252624835,-1.08373116588599,0.3543859649122807,0.961440042354187,1.0,10/15,51.52%,P2RY14;P2RX7;P2RY12;P2RY1;GPR34;P2RX4;PTAFR;P2RX5;P2RX3;P2RX6
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4076627353550372,1.0836503146736327,0.37409200968523004,0.9771617945933759,1.0,11/35,19.88%,DTWD1;TRDMT1;GATB;PUS10;AARS1;TARS2;NT5C3A;QTRT2;FTO;ALKBH1;MTFMT
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.41240357237487374,1.0807490619681301,0.36797066014669927,0.9826784161485937,1.0,14/34,21.79%,INCENP;CALM3;TAOK1;DDX3X;ALS2;IQGAP1;PARP16;MAP2K2;CCNT1;SPRY2;CAB39L;CALM1;CCNT2;CALM2
prerank,carboxy-lyase activity (GO:0016831),0.44029528659403727,1.0802945482174289,0.3874680306905371,0.9794319170566369,1.0,3/23,2.69%,AZIN2;MLYCD;UROD
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4602445543091697,1.0786902904476545,0.3891102257636122,0.9801026050074934,1.0,6/18,18.94%,PRDX5;XIAP;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,leak channel activity (GO:0022840),0.4539972491362526,1.076412369904914,0.3726790450928382,0.9832461672946554,1.0,2/18,5.33%,NALCN;KCNK2
prerank,transcription coregulator binding (GO:0001221),0.3854500673318485,1.0753050176178305,0.3793884484711212,0.9822027859356621,1.0,11/50,13.05%,HDAC3;RORA;CDK9;PHF1;EZH2;CHD6;CIT;EHMT2;PER1;USP11;EHMT1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.49529570869575223,1.075202081106256,0.3951734539969834,0.9775785119881722,1.0,6/11,19.80%,PRMT6;PRMT5;PRMT1;PRMT8;PRMT2;CARM1
prerank,pyridoxal phosphate binding (GO:0030170),0.4504211273311582,1.0740679746312451,0.37866666666666665,0.9766500209044544,1.0,3/20,8.15%,PSAT1;ABAT;OAT
prerank,protein tyrosine kinase activity (GO:0004713),0.3606407129185856,1.0735474601380028,0.35958549222797925,0.9734751901413208,1.0,16/108,11.29%,AATK;MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;WEE1;EPHA8;TEC;EPHA10;MUSK;PDGFRA
prerank,deoxyribonuclease activity (GO:0004536),0.4791656108636959,1.0735431820913952,0.4195906432748538,0.9686218709310642,1.0,3/14,6.72%,DNASE1L2;APLF;DFFB
prerank,disordered domain specific binding (GO:0097718),0.4243992504442735,1.071981647993923,0.38946015424164526,0.9691877771187344,1.0,11/23,21.79%,HSP90AA1;CALM3;DFFB;KCNA1;FKBP8;NUMA1;MDM2;CALM1;NCOA3;SMAD2;CALM2
prerank,protein phosphatase regulator activity (GO:0019888),0.3816212446923615,1.071744827834054,0.3803611738148984,0.9652666244085943,1.0,22/53,24.31%,DMPK;CALM3;RCAN2;PPP2R2C;RCAN3;PPP1R2;PPP1R9B;PPP2R5E;PPP6R3;PPP1R16A;PPP2R5D;PPP2R5A;CALM1;ARPP19;IGBP1;PPP2R2B;CALM2;PPP2R2A;PPP4R4;PPP2R5C;PPP4R1;PPP2R2D
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2315138519355475,-1.07166040041404,0.4,0.987415071031501,1.0,26/134,11.94%,ABCG2;SLCO3A1;ABCC4;SLC6A6;GJA1;SLC25A17;SLC26A7;SLC25A13;ABCC1;SLC3A2;SLC26A2;SLC7A1;SLC35B3;SLC6A9;SLCO1C1;SFXN2;SLCO2A1;SLC16A1;SLC25A32;SLC52A1;SLC36A4;CTNS;SLC39A8;SLC35D1;SLC22A6;SLC16A11
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4430796043026404,1.0704612065318857,0.39816031537450725,0.9651925802214704,1.0,8/21,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,ribosome binding (GO:0043022),0.38793393793163516,1.069598816908999,0.3764172335600907,0.9634609340811277,1.0,9/46,13.42%,SRP19;CPEB1;SEC61A2;NCLN;SHFL;YTHDF3;RACK1;SRP68;YTHDF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.34172173153912827,1.0586688770051662,0.314,0.996803464166975,1.0,87/406,18.54%,MMP12;HSF2;FOXM1;ZBTB48;NFKB1;ZNF25;ZBTB46;ZNF568;CREBZF;MLXIP;NKX2-2;GLIS2;STAT6;XBP1;RORA;TFDP1;PSPC1;MXI1;TAF4;RFX5;SNAI1;MTERF3;TCF7L2;PRDX5;TFCP2;IRF1;TBP;ZNF35;CASZ1;ARNT;ZBTB7B;TEAD1;HDAC5;ZBTB5;DBP;NFX1;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;RBL2;HOXB8;ATF2;ZBTB20;SUV39H1;FOXN3;YY1;E2F3;PARK7;PEG3;SOX6;NPM1;HDAC1;CREB3;SETX;HNRNPL;TRPS1;SMAD6;SOX5;KMT2D;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;HOXC8;TIPARP;ZFP37;SOX13;OSR1;ZFP90;TCF7;NFXL1;GABPB1;GABPB2;TBL1XR1;ZNF177;CUX1;NONO
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4886179655936866,1.0580894971959722,0.41262848751835535,0.9939844158813151,1.0,3/12,5.87%,CDK13;CDK9;BRD4
prerank,phosphatase inhibitor activity (GO:0019212),-0.34101194376013355,-1.05709453987859,0.39330543933054396,1.0,1.0,6/20,12.59%,PPME1;ENSA;URI1;STYX;LMTK2;ANP32E
prerank,CoA-ligase activity (GO:0016405),-0.3827399085012265,-1.053707108133243,0.37666666666666665,1.0,1.0,6/14,44.28%,AACS;ACSS1;ACSS2;ACSBG1;SLC27A2;ACSF3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.49558618159146295,1.052553434618857,0.40706605222734255,1.0,1.0,5/10,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3919148379226701,1.0525093207573823,0.39231664726426074,1.0,1.0,8/35,12.36%,MMP12;TAF4;POU2F1;TBP;SMARCB1;PARK7;NPM1;HDAC1
prerank,myosin II binding (GO:0045159),-0.41970851458284686,-1.0519637430454534,0.39823008849557523,1.0,1.0,6/10,30.85%,STXBP5;SHROOM4;TRIOBP;STXBP5L;SHROOM1;LLGL2
prerank,nuclease activity (GO:0004518),0.3801004353317881,1.051506204799071,0.4189189189189189,1.0,1.0,12/52,15.16%,DNASE1L2;NTHL1;RNASE1;RNASE7;DFFB;N4BP2;AEN;ENPP1;SND1;ISG20L2;DIS3L2;MRE11
prerank,ubiquitin-protein transferase activity (GO:0004842),0.34177930251521893,1.0472667600023138,0.376,1.0,1.0,94/346,21.26%,RNF157;CDC23;RNF138;MSL2;RNF8;UBE2S;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;SYVN1;RNF215;TRIM11;BRAP;FBXL14;PDZRN3;TNFAIP3;FBXO7;COP1;BARD1;TRIM56;RFFL;TRIM35;MYCBP2;RMND5A;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;RNF40;RNF168;RNF103-CHMP3;TRIM41;TRIM17;CUL4B;RNF11;CHFR;UBE2Z;MALT1;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;UBE2A;ANAPC11;ANAPC4;NEURL2;UBE2J1;CUL5;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;KLHL13;UBE2E1;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBE2L3;UBR5;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;PPP1R11;KLHL20;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;KLHL9;TRIP12;HECW2;CBLB;CNOT4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.47268611548565914,1.046344161949584,0.42718446601941745,1.0,1.0,2/13,10.98%,DNASE1L2;ENDOV
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4687741759173283,1.0444241361368058,0.4270986745213549,1.0,1.0,2/12,2.24%,KDM4D;KDM7A
prerank,death receptor binding (GO:0005123),-0.3610312454634071,-1.0441774167384763,0.3801369863013699,1.0,1.0,6/15,13.17%,DAB2IP;CASP8AP2;RIPK1;FEM1B;MADD;NGF
prerank,endopeptidase inhibitor activity (GO:0004866),0.3632282987818964,1.043763083017938,0.4278131634819533,1.0,1.0,17/82,20.46%,BIN1;USP14;RENBP;SERPING1;CARD16;SPOCK1;UBE2Z;APP;TFPI;SERPINA2;SPOCK2;SERPINE1;SERPIND1;ANXA2;TIMP2;PROS1;SERPINF1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.40007465294180666,-1.0429493166092696,0.39589442815249265,1.0,1.0,5/12,8.02%,NCBP3;AGO2;DCPS;EIF4E;NCBP1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.38733613037755876,1.0422348584133285,0.437862950058072,1.0,1.0,3/42,4.67%,CDKN2D;HEXIM1;CCNC
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4409667200850931,1.0392382101957292,0.42933333333333334,1.0,1.0,5/19,17.61%,CD24;NRG3;EGF;NRG1;ABI1
prerank,alpha-actinin binding (GO:0051393),0.42028985017924403,1.0367667279507915,0.4116161616161616,1.0,1.0,2/24,1.71%,PDLIM2;PDLIM7
prerank,ATP hydrolysis activity (GO:0140603),0.3793069123127918,1.0345129429951603,0.4435389988358556,1.0,1.0,8/41,12.16%,HSP90AA1;MYO19;DDX3X;ATP2B1;TOR1B;VCP;RHOBTB3;VPS4B
prerank,AMP binding (GO:0016208),-0.41230235057649867,-1.03383781857116,0.4228395061728395,1.0,1.0,9/11,42.69%,MPPED2;PRKAG1;PFKM;ACSS2;PRKAG3;PFKL;APRT;PFKP;PYGL
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4140775051976101,-1.0323286794693172,0.4221556886227545,1.0,1.0,5/10,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4140775051976101,-1.0323286794693172,0.4221556886227545,1.0,1.0,5/10,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,histone acetyltransferase activity (GO:0004402),-0.2950112002073866,-1.0309951099029329,0.4171779141104294,0.9944240906360259,1.0,11/30,19.34%,EPC1;KAT7;BAZ1A;KAT2B;MCM3AP;NAA40;EP300;KAT6B;BRCA2;KAT8;NAA60
prerank,microtubule binding (GO:0008017),0.33508541908657213,1.0297541770924652,0.4267068273092369,1.0,1.0,57/222,21.52%,PSRC1;CFAP157;FSD1;CCDC61;CCDC170;REEP4;DNM1;WHAMM;MAPRE3;KIF3A;MDM1;RAE1;NEFH;ALMS1;CDK5;MTCL1;KIF3C;MACO1;CAMSAP2;GAS2L1;RMDN2;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;TPGS1;KIF5C;MAPT;MAP1LC3B;EML2;DNM1L;VAPB;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;CCDC88A;EML3;KIF20B;KRIT1;MAP6D1;RPS3;PAFAH1B1;KIF6;DCX;MAP6;MAP4K4;FGF13;CLASP2;MID2
prerank,titin binding (GO:0031432),0.46237633631083785,1.0294725353499758,0.43899018232819076,1.0,1.0,4/13,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,syntaxin-1 binding (GO:0017075),0.4213767371294883,1.0270017458089296,0.45222929936305734,1.0,1.0,7/22,16.55%,UNC13A;VAMP3;CPLX1;SNAP25;SYT1;DAPK1;NSF
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.40253939040326275,1.0262390053771895,0.45792079207920794,1.0,1.0,9/30,18.94%,CARD16;PRDX5;XIAP;SPOCK1;UBE2Z;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,CARD domain binding (GO:0050700),-0.3741543639636504,-1.0261836944956195,0.40425531914893614,0.9965778007779242,1.0,7/14,22.71%,NOD1;CASP4;MAVS;CARD10;IRGM;CARD14;BCL10
prerank,protein kinase activator activity (GO:0030295),0.3633638547376196,1.0256339468407425,0.44759825327510916,1.0,1.0,18/60,19.00%,INCENP;CALM3;TAOK1;DDX3X;STK11;CD24;GPRC5B;ALS2;IQGAP1;PARP16;NRG1;MAP2K2;DAXX;SPRY2;ABI1;CAB39L;CALM1;PRKAG2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.40693625959134594,-1.0251724884734215,0.43322475570032576,0.9868807906114885,1.0,5/11,13.16%,ATP8B1;ATP10A;ABCA4;ATP11C;ATP11A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4696250062585282,1.0228158521109763,0.4588068181818182,1.0,1.0,4/12,15.76%,PDE7B;PDE4A;PDE8B;PDE4B
prerank,I-SMAD binding (GO:0070411),0.4661711372608227,1.0225553460691843,0.46099290780141844,1.0,1.0,8/13,22.11%,SMAD9;TGFB1I1;SMAD6;SMURF1;TGFBR1;SMAD7;SMAD2;SMAD3
prerank,semaphorin receptor activity (GO:0017154),0.4733318865253126,1.0220059470012768,0.4514200298953662,1.0,1.0,3/11,8.09%,PLXNA2;NRP1;PLXNA1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3765486034349431,1.0212478500077942,0.47308132875143183,1.0,1.0,14/42,21.54%,ANXA1;SIRPA;DSCAM;JAM3;BAIAP2;RAB10;CD47;NPTN;ANXA2;PLXNB3;CNTN2;NEXN;S100A11;PDLIM1
prerank,5'-3' exonuclease activity (GO:0008409),0.46573054876336395,1.0202535641464454,0.4755927475592748,1.0,1.0,4/14,15.16%,DCLRE1A;CPSF3;XRN1;MRE11
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4324436401871084,1.019792084948667,0.45139813581890814,1.0,1.0,5/18,16.83%,FAR2;ALDH1A2;AKR1B10;FAR1;ALDH3A2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.36266339380975465,1.0177418235825109,0.46078431372549017,1.0,1.0,12/60,13.11%,MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;ROR2
prerank,serine-type endopeptidase activity (GO:0004252),0.35522002196456065,1.0167179649334235,0.47280334728033474,1.0,1.0,10/80,17.07%,RHBDL3;PCSK5;PCSK2;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,nucleosomal DNA binding (GO:0031492),0.42361619109441584,1.0160286481423382,0.45634920634920634,1.0,1.0,6/21,12.64%,SMARCC2;RBBP4;SMARCB1;MTA2;HDAC1;RCC1
prerank,cytokine activity (GO:0005125),0.33937828609213466,1.0158186651254717,0.46366427840327534,1.0,1.0,11/131,14.45%,WNT2B;WNT5A;IL34;BMP6;IL33;CXCL12;WNT4;BMP5;NRG1;TGFB1;SLURP1
prerank,GABA receptor activity (GO:0016917),-0.3237466676637163,-1.01549925269392,0.4336283185840708,1.0,1.0,7/21,21.34%,GABRB1;GABRG2;GPR156;GABRA5;GABRA4;GABRG1;GABRA1
prerank,growth factor receptor binding (GO:0070851),0.3510352165736397,1.0145874174877334,0.48210526315789476,1.0,1.0,10/95,11.48%,FGF20;FGF9;FGF10;PIBF1;SDCBP;FRS2;EGF;KL;PDGFRA;CNOT9
prerank,Toll-like receptor binding (GO:0035325),-0.3948699281981824,-1.0145296551611171,0.41875,0.9959009489583919,1.0,3/11,10.18%,DAB2IP;UNC93B1;TOLLIP
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.39429383690056385,-1.014384206395248,0.44518272425249167,0.9836397903105747,1.0,7/12,27.23%,CASP8AP2;BCL2L13;NOD1;APAF1;BAD;ATP2A3;RPS27L
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4188970727979097,1.0138595846453085,0.4772727272727273,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4188970727979097,1.0138595846453085,0.4772727272727273,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,histone acetyltransferase binding (GO:0035035),-0.31546307359269715,-1.0124837588740794,0.4576271186440678,0.9772871205072673,1.0,5/21,8.90%,MEF2A;KANSL1L;STAT1;HIF1A;TP53
prerank,GTPase regulator activity (GO:0030695),0.3301426096495821,1.0120322889372908,0.4804804804804805,1.0,1.0,69/212,21.96%,ELMOD1;MTSS2;TSC2;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;NRP1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;RANBP3L;SIRPA;RAP1GAP;ARRB1;ARHGAP42;RAP1GAP2;RABGAP1L;GPSM1;ARHGAP24;TBC1D20;RIC8B;USP6NL;RTKN;GPSM2;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;ARAP1;ADAP1;PDE6D;RABGAP1;ARHGAP29;IPO7;DNM1L;TBCD;ARHGEF6;ITGB1BP1;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;GPS2;ADGRB3;RANBP2;RANBP3;KRIT1;RALGAPB;DLC1;STARD13;RAB3GAP2;RALGDS;CHN1;NPRL2;PREX1;ARHGAP26;LLGL1;ARHGAP35;ARFGAP3
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3889575037079078,-1.011359407742178,0.4380952380952381,0.96866893143916,1.0,2/12,8.80%,STAT1;TRAP1
prerank,protease binding (GO:0002020),0.3444083769718602,1.0101494243866969,0.487551867219917,1.0,1.0,27/99,20.98%,SELENOS;BIN1;ATP9A;SYVN1;CCBE1;TNFAIP3;CARD16;RFFL;BDKRB2;CHMP3;VCP;SART3;BCL2;COL1A2;PARK7;PSAP;F3;DERL1;TRIP4;SERPINE1;ANXA2;FLOT1;TIMP2;NFRKB;ITGAV;NTRK2;ITGB1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.41078113809522354,1.0095840228694297,0.4645161290322581,1.0,1.0,5/22,8.82%,PRPF8;TNFAIP3;OTUD7A;SQSTM1;RNF168
prerank,carboxylic ester hydrolase activity (GO:0052689),0.34643577389697583,1.0093095006187174,0.4869109947643979,1.0,1.0,11/85,11.46%,LPL;LYPLAL1;PON2;PON3;PRDX6;GDPD3;AARS1;ENPP2;PGAP1;APMAP;TARS2
prerank,sialyltransferase activity (GO:0008373),0.42375053967146986,1.0083907019904885,0.4607329842931937,1.0,1.0,5/20,8.55%,ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;ST3GAL5
prerank,nucleotidyltransferase activity (GO:0016779),-0.323708654760073,-1.00775687808388,0.45021645021645024,0.9680872966851966,1.0,12/19,41.83%,NUDT5;TENT2;REV1;PAPSS2;TUT1;TUT4;TERT;YRDC;CGAS;TUT7;CRPPA;MOCS3
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3145276278126366,-1.0067381360270873,0.4307692307692308,0.9593696801699333,1.0,7/25,14.84%,TGFA;FER;TNK2;SNX2;PLSCR1;ARF4;HIP1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.41064260703726263,-1.0062550226444607,0.44680851063829785,0.9492695922665336,1.0,9/10,56.85%,NOX1;CYBA;NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4536186881486663,1.0049198517911024,0.48179271708683474,1.0,1.0,3/13,17.77%,DDT;EHHADH;ECH1
prerank,single-stranded RNA binding (GO:0003727),0.3707096022234918,1.0046966846881833,0.4730195177956372,1.0,1.0,8/43,12.58%,ILF3;DDX3X;CNBP;DHX58;LACTB2;SRA1;ENDOV;AGO3
prerank,potassium ion antiporter activity (GO:0022821),0.437827104556603,1.0046034526075256,0.4859154929577465,1.0,1.0,4/15,15.90%,SLC24A5;SLC24A4;SLC9A7;SLC9A6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.44001671943226567,1.004506023224826,0.4725274725274725,1.0,1.0,5/15,23.01%,ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1;ALDH2
prerank,neuropeptide hormone activity (GO:0005184),-0.3171964389151842,-1.003391407455393,0.44075829383886256,0.9469249095561634,1.0,19/22,65.04%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPY;NPFF;PNOC;NMB;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,metal ion binding (GO:0046872),0.32378525662299884,0.9991359283258088,0.497,1.0,1.0,106/477,21.81%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;HMGCLL1;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;NUAK2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;ABL1;PPA2;RASGRP2;STK11;BRSK2;SPARC;RAP2A;ADGRV1;RCN3;SIK1;SPOCK1;CRACR2A;DHX36;CDH11;NUDT12;PITPNM3;ENPP2;BRSK1;NUDT3;IGFBP3;ENDOV;MCTP2;BNIP2;IQGAP1;ENPP1;TDP2;FBN1;SYT1;SPOCK2;HPRT1;GCLC;PAM;LRP1;EYA2;CDH18;EPHX2;SLIT1;SLIT3;DIS3L2;EFHD1;NT5C3A;ANXA2;TPPP;MAN1C1;OXSR1;APOE;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SRPK1;SCUBE1;CDC42BPB;TRIM27;CALM1;MTPAP;TPM4;IMPA1;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;EXD2;GSN;SYT11;SYT12;CDH10;SDF4;CALM2;TRIM26
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.47529814199628484,0.9982767240841581,0.491044776119403,1.0,1.0,3/10,15.46%,CASP7;CASP9;CASP2
prerank,mRNA binding (GO:0003729),0.32404893201996343,0.9981971518596033,0.5170340681362725,1.0,1.0,74/249,21.45%,CPEB1;KHSRP;GNL3;SLBP;RBM4B;RBM47;PCBP4;ZFP36L1;DDX3X;SRSF5;IGF2BP2;FUBP1;SF3B1;CNBP;DCP1B;CELF2;CELF1;HNRNPK;DHX33;KHDRBS2;SRSF1;RNF40;PABPC4;RBMS3;DHX36;PUM3;HNRNPM;PABPC1;MYH10;HDLBP;RBFOX2;CSTF2T;SHFL;RC3H2;RBMS1;NUDT21;EIF4G2;RBMS2;YTHDF3;PARK7;HNRNPA0;MYEF2;HNRNPL;YTHDF1;TRA2B;LUC7L2;CSDC2;NOVA1;HNRNPA2B1;MRPL13;HNRNPLL;CELF5;DDX5;GRSF1;YTHDC1;EIF4G3;FMR1;ZC3H12C;LUC7L3;CPSF6;PCBP2;RSL1D1;SAMD4B;YTHDF2;RPS3;CSTF3;CIRBP;HNRNPU;GEMIN5;TPR;PTBP1;RPL7;ANGEL2;SRRM2
prerank,RNA methyltransferase activity (GO:0008173),0.41853820363548533,0.9980277813211018,0.48874172185430464,1.0,1.0,2/19,3.32%,TRDMT1;FBL
prerank,sterol binding (GO:0032934),0.3570992494480204,0.9969609515658981,0.5050167224080268,1.0,1.0,12/56,13.54%,SCAP;RORA;STARD5;ERLIN2;VDAC2;OSBPL11;SOAT1;INSIG1;PTCH1;STARD3;VDAC1;SIDT1
prerank,estrogen receptor binding (GO:0030331),-0.2782064192655345,-0.9964436113482126,0.4585635359116022,0.9567561675689423,1.0,6/32,5.09%,CNOT1;LATS1;LEF1;NCOA6;MED1;DCAF1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.44048884284876555,0.9950872600784574,0.492176386913229,1.0,1.0,4/14,21.60%,SLC7A11;SLC1A3;SLC1A2;SLC38A7
prerank,phosphate ion binding (GO:0042301),0.47851820558335467,0.9949969549580746,0.49924357034795763,1.0,1.0,1/10,3.77%,RPH3A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.2885638969179797,-0.994979015116236,0.4434782608695652,0.9501558527371188,1.0,9/27,15.29%,SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC25A14;SLC5A5
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.40171496657924016,0.9904285519311969,0.4948849104859335,1.0,1.0,8/23,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,nuclear localization sequence binding (GO:0008139),0.42339787923132166,0.9889225926113017,0.5006675567423231,1.0,1.0,8/18,20.31%,KPNA3;BRAP;KPNB1;NUP214;TNPO1;NUP153;KPNA1;CABP1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2716111384437464,-0.9862776854348818,0.47023809523809523,0.9648640781524,1.0,16/37,26.40%,SLCO3A1;SLCO1C1;SLCO2A1;COX4I1;COX5A;COX8A;NDUFA4;SLC22A6;COX7A2L;COX6A1;SLC16A7;COX15;UQCR10;ATP13A3;UQCRQ;UQCR11
prerank,leucine zipper domain binding (GO:0043522),0.46193050026583815,0.9848219079656757,0.5015015015015015,1.0,1.0,3/10,15.37%,MRTFA;DDIT3;PAWR
prerank,phospholipase activity (GO:0004620),0.3404818054351076,0.9791758931092063,0.504875406283857,1.0,1.0,15/67,21.23%,LPL;GPLD1;SMPD2;LYPLAL1;PRDX6;GDPD3;PITPNM3;ENPP2;SMPD4;DDHD2;PNPLA7;GDE1;SMPD1;ABHD16A;PLCL1
prerank,iron ion binding (GO:0005506),0.353293921289504,0.978222308285173,0.519406392694064,1.0,1.0,14/48,20.47%,KDM7A;ISCA2;AGMO;ALKBH3;EGLN2;ETHE1;DNAJC24;HEPH;FTO;ABCE1;ALKBH1;TET1;NFU1;FTH1
prerank,transition metal ion binding (GO:0046914),0.3151519359849335,0.9765063900978538,0.591,1.0,1.0,96/397,21.53%,GALT;MMP12;ADH5;XPNPEP3;SMPDL3B;NQO2;SIRT2;KDM7A;ISCA2;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;GALNT4;TIMM13;DHX58;LACTB2;ABL1;ZEB1;TARS1;GPC1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;POMGNT1;FAM20C;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;AGMO;ENPP2;CUTA;KDM2B;COX17;ZCCHC4;PAPPA;ENPP1;PARK7;SOD2;SOD3;LANCL1;TDP2;ZMYM2;PAM;ADAMTS3;ETHE1;DNAJC24;BBOX1;GLRA1;LACC1;PPM1M;HEPH;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;MOXD1;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;ABCE1;SLC11A2;SMPD1;TIMP2;TET1;MTPAP;KLF4;IMPA1;NFU1;MMP16;FTH1;CTCF;PTGR2;ZBTB32;TAB3;EXD2;TES;CBLB;ME1;COMMD1;ATOX1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.385624607658506,-0.9760957319161624,0.4694533762057878,0.9856954348924701,1.0,9/11,61.46%,HCN2;HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,methylated histone binding (GO:0035064),0.34331838808893944,0.9758653639244771,0.5284463894967177,1.0,1.0,15/62,18.61%,CBX8;KDM7A;CHD8;PHF1;CHD5;DPF2;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,translation initiation factor activity (GO:0003743),-0.2684208268931178,-0.9745164796227707,0.4892086330935252,0.9794088457988355,1.0,17/36,26.78%,EIF3E;EIF2S2;EIF2A;AGO2;EIF4E;EIF4A2;EIF2D;EIF3B;EIF5;EIF3K;EIF3I;EIF2B5;EIF2B2;EIF3D;EIF3L;EIF2B4;MTIF3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4527373043525691,0.9728807362278937,0.518463810930576,1.0,1.0,3/11,15.46%,CASP7;CASP9;CASP2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3738093924803882,0.9723038687780563,0.524330900243309,1.0,1.0,9/31,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3016399013363563,-0.9722565908993516,0.4656084656084656,0.9759110562075355,1.0,10/26,20.83%,ABCG2;SLC6A6;SLC16A2;SLC16A6;SLC16A1;SLC16A11;SLC5A6;SLC16A9;SLC16A4;SLC16A7
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.30697005708008407,-0.9712332173480633,0.48068669527896996,0.9684447732625621,1.0,6/21,9.65%,WASF2;PRRC1;EZR;PRKACA;AKAP9;AKAP7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.39553998127831913,0.9698301616861469,0.5148771021992238,1.0,1.0,1/22,0.41%,DUSP18
prerank,LRR domain binding (GO:0030275),0.4272690816854723,0.9692842685444656,0.5310734463276836,1.0,1.0,4/14,15.37%,MRTFA;DDIT3;ROBO1;PAWR
prerank,U6 snRNA binding (GO:0017070),0.43230837020775004,0.9688070464057328,0.5128939828080229,1.0,1.0,3/14,11.06%,LSM7;PRPF8;SART3
prerank,platelet-derived growth factor binding (GO:0048407),-0.3848118930897663,-0.9678177098937775,0.4803921568627451,0.9683379434433494,1.0,5/11,19.78%,COL5A1;COL6A1;COL4A1;PDGFA;COL1A1
prerank,triglyceride lipase activity (GO:0004806),0.4027699649510518,0.9643496798844438,0.5384615384615384,1.0,1.0,1/20,0.96%,LPL
prerank,thioesterase binding (GO:0031996),0.4481473272405012,0.9641204971533082,0.512937595129376,1.0,1.0,1/11,2.78%,RAC1
prerank,RNA polymerase II complex binding (GO:0000993),-0.27945032963486993,-0.9633866831014615,0.515527950310559,0.9708236200495459,1.0,11/32,15.16%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2;PCIF1
prerank,hyaluronic acid binding (GO:0005540),0.45834688009457897,0.9621205048631947,0.5072674418604651,1.0,1.0,1/10,1.16%,LYVE1
prerank,amyloid-beta binding (GO:0001540),0.33225405504539435,0.9617419080288149,0.5553191489361702,1.0,1.0,18/79,18.62%,FCGR2B;PFDN4;EPHB2;GRIN1;ATP1A3;VBP1;GRIN2A;LRPAP1;PFDN1;GRIA1;LRP1;GRIA2;HSPG2;ITM2B;APOE;PFDN2;SORL1;ITM2C
prerank,metallocarboxypeptidase activity (GO:0004181),0.38596648657687543,0.9599015840644498,0.5471464019851117,1.0,1.0,6/26,19.23%,CPXM1;AGBL3;PEPD;CPXM2;AGBL4;AGTPBP1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.38231480839903836,-0.9598063377840206,0.513595166163142,0.9712457124834085,1.0,6/10,19.34%,NAA40;EP300;MSL3;BRCA2;KAT8;NAA60
prerank,TBP-class protein binding (GO:0017025),-0.30071331922011973,-0.959032800875902,0.5254237288135594,0.9634017099574136,1.0,10/21,23.64%,THRA;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,retinoid X receptor binding (GO:0046965),-0.3648181537464487,-0.9570841503963308,0.4805194805194805,0.9588223183034795,1.0,7/11,28.03%,NCOA6;RARG;MED25;NRIP1;PPARG;NR4A2;ARID5A
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.42882457458078405,0.9556909822120045,0.5576642335766423,1.0,1.0,2/13,11.52%,BMP6;BMP5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3043156844558534,0.9490227527076383,0.732,1.0,1.0,168/830,20.84%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;FOXM1;ZBTB48;POU5F2;NFKB1;ZNF25;ZBTB46;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;TFDP1;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;TBP;ZNF35;ZIC3;CASZ1;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;NFX1;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;RBL2;HOXB8;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;PEG3;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383;PROX2;FOXJ3;EBF1;ZIC2;TRPS1;ESRRG;BCL6;SOX5;RFX3;NR2C2;SATB1;TCF7L1;TCF3;FOXC2;CIC;GTF2IRD1;MAF;HOXC8;CLOCK;KDM6B;THRAP3;ZFP37;SOX13;ZBTB41;OSR1;ZFP90;TCF7;NFXL1;NSD1;MEIS2;RELB;ZNF177;CUX1;BCL11B;CHD2;FOXD1;KLF13;SOX4;ZIC4;RPS3;KDM6A;MITF;KLF4;GABPA;NFIA;PRDM15;DNMT3A;E2F6;PKNOX1;GLIS3;TBPL1;HDX;HNRNPU;CTCF;ZNF219;CREB5;ZBTB32;MYNN
prerank,RNA binding (GO:0003723),0.3035076178675314,0.9479971861867054,0.795,1.0,1.0,305/1321,18.55%,ILF3;FASN;SRP19;NHP2;KHSRP;HEXIM1;AFF2;BICC1;RAVER2;LSM6;EXOSC1;CDC42EP4;EXOSC3;APTX;GNL3;TARBP2;YARS1;DHX40;ANXA7;DGCR8;DDX17;NOP9;PSMD4;LSM7;DNM1;TRMT2A;DDX18;TBRG4;TOE1;SUGP2;CHERP;HMGB3;DDX19B;SLBP;EBNA1BP2;RBM4B;PARP1;FAM50A;HSP90AA1;EXOSC7;EXOSC2;RBM3;PRKRIP1;TRUB2;FBL;U2AF1;SRSF2;DIMT1;RBM47;PCBP4;LRRC47;ANP32A;NOP56;RPL22L1;ZFP36L1;PRPF8;ZCCHC8;SRSF12;DDX3X;PSPC1;YARS2;DHX15;RAE1;POLR2B;CDK13;SRSF5;SLTM;SPATS2;TBCA;IGF2BP2;FUBP1;DRG2;SF3B2;SF3B1;DHX30;STIP1;DCN;CNBP;MTCL1;RBM39;DCP1B;CELF2;DHX58;LACTB2;PUS10;ARL6IP4;CARS1;DHX8;SARS2;BARD1;ZC3H4;NOL12;SRSF3;CELF1;TRIM56;HNRNPK;AKAP8L;FUS;MPHOSPH10;TIA1;RTF1;SRSF9;DHX33;CCT6A;CKAP4;HADHB;IFIT3;SF3A1;WRAP53;AARS1;KPNB1;KHDRBS2;DDX46;PEF1;RCAN3;NFX1;PRPF6;SRSF1;FNDC3B;SRP9;TBL2;EIF1B;UBA1;GCN1;BUD23;MDH2;WDR6;USP10;EPRS1;RBM18;XRCC6;PABPC4;KIN;RCC1L;HNRNPD;RBMS3;DHX36;PPP1CC;PPIB;MRPL21;PUM3;MRPL10;RBM34;LIN28B;CPSF7;HNRNPM;VCP;NOL7;ANKHD1;PUS7;PABPC1;PSIP1;NKRF;ZC3H7B;YWHAG;MRPL1;ESF1;RPL35A;RPS25;MTREX;MYH10;TOP1;RBM10;HDLBP;RBFOX2;ZC3H14;ENDOV;SART3;CSTF2T;SHFL;SARS1;RC3H2;MAZ;RPS15;EIF4E2;RBMS1;MYO5A;YY1;TRMT1;JAKMIP1;NUDT21;EIF4G2;DYNC1LI1;RBMS2;ATXN2L;NEMF;PTCD2;YTHDF3;DHX16;FLNB;PARK7;EIF1AX;EIF1;NPM1;CPSF3;TIAL1;HNRNPA0;CFAP20;RPL9;AGO3;PEG10;RACK1;MYEF2;HNRNPH3;PRMT1;DHX57;SETX;SRP68;RBM45;HNRNPL;MRPL3;GSPT1;TLR3;METAP2;YTHDF1;TRA2B;LUC7L2;SIDT1;RPP30;C1D;LRP1;SUCLG1;RPL4;SND1;SCAF4;KHDC4;FAM98A;TUBA1B;MAPT;CSDC2;BMS1;NOVA1;ROCK2;CHCHD1;HNRNPA2B1;RBM26;PRPF40A;HELB;USO1;BCLAF1;XRN1;MRPL13;RP9;ISG20L2;HNRNPLL;NUCKS1;CELF5;SPTBN1;TNPO1;HSPD1;RPL7L1;CCDC9;TFB1M;DDX5;GRSF1;AHNAK;SAFB2;HNRNPDL;ZC3HAV1;YTHDC1;NUDT16L1;SNW1;LAS1L;DDX19A;EIF4G3;ANXA2;DNAJC21;FMR1;UBE2L3;THRAP3;RPL23A;OAS2;MSI1;TOP3B;ZC3H7A;MTDH;ZC3H12C;MRPL15;DHX34;PTCD1;SON;DHX29;SRRM1;PNISR;BCCIP;NSA2;FASTKD1;PRPF40B;LUC7L3;CPSF6;RBM27;ZC3H18;PCBP2;MAP4;TENT5A;SMG7;ASS1;BRIX1;MECP2;RBM22;HLTF;NOL4;SRPK1;NONO;BAG4
prerank,MHC protein binding (GO:0042287),-0.30550826532335296,-0.9479557824844382,0.5303643724696356,0.9772227988512702,1.0,8/20,31.85%,TAPBP;TAP2;ATP5F1B;ABCB9;CD81;TAP1;TUBB4B;CD74
prerank,acetylcholine receptor activity (GO:0015464),-0.2940487067539541,-0.9474212781004474,0.5353982300884956,0.9688772358850891,1.0,3/22,14.43%,CHRM3;CHRFAM7A;CHRNA7
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.3181351853915431,-0.9464745272359028,0.49130434782608695,0.9618357759185431,1.0,4/17,5.50%,ATP8B1;ATP10A;PITPNA;PITPNC1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.30462703874771785,0.9464282598113196,0.738,1.0,1.0,100/730,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;PRMT5;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3765049028618186,-0.9459843200620957,0.5162241887905604,0.9538109944410129,1.0,4/10,20.27%,NAA15;NAA25;NAA60;NAA80
prerank,GTPase activator activity (GO:0005096),0.3055070613930685,0.9445482261865558,0.6696696696696697,1.0,1.0,79/313,18.77%,ELMOD1;MTSS2;TSC2;SH3BP5;TBC1D7;SGSM3;RUNDC1;NUCB2;RAP1GDS1;RGS10;ARHGEF10;NRP1;GAPVD1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;RANBP3L;KALRN;MYCBP2;RAP1GAP;ARRB1;ARHGAP42;DOCK8;RAP1GAP2;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;RABGAP1L;VAV2;ARHGAP24;TBC1D20;DENND4C;DENND5A;RIC8B;USP6NL;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;MON1A;ARAP1;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;ADAP1;EEF1B2;RABGAP1;ARHGAP29;DNM1L;CYTH1;FARP2;DNMBP;TBCD;ARHGEF6;EPS8L1;DENND6A;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;ADGRB3;RANBP2;RANBP3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3906211598815834,0.9435024034622876,0.5788079470198676,1.0,1.0,6/20,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,zinc ion binding (GO:0008270),0.3064532158029561,0.9433955628120154,0.6342685370741483,1.0,1.0,67/293,21.25%,GALT;MMP12;ADH5;SMPDL3B;NQO2;SIRT2;KDM7A;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;TIMM13;DHX58;LACTB2;ZEB1;TARS1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;ENPP2;KDM2B;ZCCHC4;PAPPA;ENPP1;LANCL1;ZMYM2;PAM;ADAMTS3;DNAJC24;BBOX1;GLRA1;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;SMPD1;TIMP2;TET1;KLF4;MMP16;CTCF;PTGR2;ZBTB32;TAB3;TES;CBLB
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.37275580665411173,-0.9432719436111766,0.5045592705167173,0.9522685437166324,1.0,9/11,62.74%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,GABA receptor binding (GO:0050811),0.43859383113628175,0.9423755328487748,0.5488721804511278,1.0,1.0,3/11,15.81%,PLCL2;JAKMIP1;TRAK1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3032115412124943,0.9422930080298559,0.747,1.0,1.0,99/731,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;FOXN3;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,androgen receptor binding (GO:0050681),0.3707374389401831,0.9409266921767512,0.5569948186528497,1.0,1.0,9/25,19.08%,WIPI1;TGFB1I1;PRPF6;PARK7;DDX5;SNW1;DAXX;NSD1;PRMT2
prerank,mRNA methyltransferase activity (GO:0008174),0.42754159183738855,0.9405110974921926,0.5282199710564399,1.0,1.0,1/12,0.77%,TRMT61B
prerank,bHLH transcription factor binding (GO:0043425),-0.2972822817616361,-0.940121992243795,0.5510204081632653,0.951543557509477,1.0,6/19,11.70%,TCF12;SIRT1;MAP3K10;LMO2;USF2;PSMD9
prerank,ATPase activator activity (GO:0001671),-0.30889388352528574,-0.9397733961877075,0.5263157894736842,0.9432527570057029,1.0,8/20,22.77%,ATP1B3;DNAJC15;DNAJC1;ATP1B1;DNAJA2;DNAJB2;DNAJA1;AHSA1
prerank,BMP receptor binding (GO:0070700),0.428831807045262,0.9388168737668812,0.5545722713864307,1.0,1.0,2/12,11.52%,BMP6;BMP5
prerank,GTPase activity (GO:0003924),0.30508371179206195,0.9350465639831899,0.649848637739657,1.0,1.0,42/192,18.38%,GPN2;ATL1;GBP3;DNM1;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;GNAS;DRG1;RHOBTB3;RAB3B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;GNAQ;MRAS;RRAS2;RAB6A;ARL8B
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.34404503152216903,-0.9345490528844992,0.5324675324675324,0.9488288117071317,1.0,6/12,22.25%,CNOT1;NOCT;PARN;CNOT8;CNOT7;CNOT2
prerank,endodeoxyribonuclease activity (GO:0004520),0.3909306521401019,0.9339551797203259,0.5647530040053405,1.0,1.0,6/20,19.43%,APLF;ENDOV;MRE11;RAD50;RBBP8;RPS3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4285841932176354,0.9336748303633761,0.5608695652173913,1.0,1.0,3/12,14.04%,PIK3R1;FRS2;BLNK
prerank,MAP kinase phosphatase activity (GO:0033549),-0.36004106465557917,-0.9325355357170483,0.532258064516129,0.9456278125827229,1.0,5/12,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,ephrin receptor binding (GO:0046875),0.3837482449233085,0.9319971456118411,0.5639686684073107,1.0,1.0,6/21,20.59%,ABL1;EFNB3;EFNB2;CBL;LYN;CHN1
prerank,serine-type peptidase activity (GO:0008236),0.32042172024098153,0.9303010247092273,0.6185031185031185,1.0,1.0,11/96,17.07%,RHBDL3;PCSK5;PCSK2;HTRA3;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,lipoprotein particle binding (GO:0071813),0.3785986127005163,0.9288429520752693,0.5627425614489003,1.0,1.0,4/20,17.95%,LPL;MAPT;HSPD1;SORL1
prerank,phospholipase binding (GO:0043274),0.413041679429868,0.9277302353886755,0.5563689604685212,1.0,1.0,4/13,20.16%,PDPK1;BLNK;PAFAH1B1;ARHGAP6
prerank,clathrin adaptor activity (GO:0035615),-0.3362984729063201,-0.9268077001011894,0.5403225806451613,0.9517288799282109,1.0,5/15,18.44%,AP2A2;HIP1;AP1M1;AP2M1;LDLRAP1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3522732647231151,-0.9252708220441569,0.5181518151815182,0.9472329175157158,1.0,3/12,8.71%,BACE2;BACE1;DDI2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.30406461268331453,0.922915324205588,0.6764112903225806,1.0,1.0,42/181,19.94%,HDAC3;TEAD3;DUSP26;BBS10;SMARCD3;COMMD6;MIER2;TAF4;TCF7L2;BBS7;TBP;TACC1;ARNT;SMARCB1;HDAC5;TTC8;CDK5RAP3;HDAC4;PRRX1;RBL2;ATF2;TAF6;JUP;RBPJ;MTA2;NPM1;TADA3;HDAC1;PIAS3;TCF3;FAF1;SNW1;TRIP4;MTDH;ANXA4;RBBP8;ATN1;NCOR2;NCOA3;KLF4;PIAS1;MIER1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3302856926229317,0.9226473762265123,0.6017797552836485,1.0,1.0,7/51,10.92%,SLC4A4;SLC35D2;SLC22A4;ANKH;SLC20A2;CLCN4;SLC22A8
prerank,ATP binding (GO:0005524),0.30254180415036896,0.9222950335166683,0.7151454363089268,1.0,1.0,60/266,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,voltage-gated anion channel activity (GO:0008308),0.40229471159953506,0.920966487427385,0.5882352941176471,1.0,1.0,4/15,13.34%,CLCN2;VDAC2;CLCN4;VDAC1
prerank,Tat protein binding (GO:0030957),-0.3725401142099868,-0.9205644981562382,0.5514285714285714,0.9510443117608035,1.0,3/10,8.04%,MDFIC;ACTB;CTDP1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.29872513568739384,0.9200547957699747,0.6983967935871743,1.0,1.0,67/269,18.55%,PTPRN;UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;HGS;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CDK5RAP3;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;TRIP4;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3696701342511205,-0.9198440264989234,0.5391849529780565,0.9443137966011413,1.0,2/10,7.61%,ADARB2;APOBEC1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.28888036337795564,-0.9198122096102538,0.5767634854771784,0.9358301982143858,1.0,3/21,14.43%,GRM1;CHRFAM7A;CHRNA7
prerank,phosphatase binding (GO:0019902),0.30678404073752313,0.9189100385401984,0.632398753894081,1.0,1.0,34/105,22.66%,TSC2;EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;DLG3;SIRPA;RCAN3;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;MAGI2;RACK1;ANAPC4;TRPC4AP;STX17;MTMR4;JAK1;TERF2IP;ANAPC5;KIFAP3;SYTL2;SPTBN4;SMAD2;TRAF2;CNST;SMAD3;ITGA1;MAP2K7
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.27017862577650426,-0.9179528124011839,0.56,0.9323962628471584,1.0,8/25,23.25%,PLEK;ZFYVE1;DAPP1;HIP1;ARAP3;KIF16B;AKT1;FCHSD2
prerank,receptor tyrosine kinase binding (GO:0030971),0.32099079708164907,0.9149592696176431,0.6067538126361656,1.0,1.0,12/56,14.97%,PIK3R1;SQSTM1;FRS2;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.3232799159365085,-0.9148136003230974,0.5447761194029851,0.9321340333539222,1.0,9/16,36.90%,SLC25A13;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,ribosomal small subunit binding (GO:0043024),0.3820053277455583,0.9135608184710794,0.5867208672086721,1.0,1.0,6/17,18.76%,DDX3X;EIF1B;EIF1;NPM1;DHX29;ABCE1
prerank,chemorepellent activity (GO:0045499),0.3638790418105517,0.9128302424754996,0.5924528301886792,1.0,1.0,6/25,15.56%,EPHA7;NRG3;SEMA3D;NRG1;SEMA3E;SEMA3A
prerank,MHC class I protein binding (GO:0042288),-0.3334836245941871,-0.9114803565514674,0.5605536332179931,0.9326088976588848,1.0,6/13,29.56%,TAPBP;TAP2;ATP5F1B;ABCB9;TAP1;TUBB4B
prerank,MAP kinase kinase activity (GO:0004708),0.39986141455944924,0.9113918473545012,0.5918367346938775,1.0,1.0,6/15,23.76%,PAK3;MAP2K2;MAP2K7;MAP2K3;MAP2K1;MAP2K6
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.24616683935754072,-0.910072571479911,0.6375,0.9278198584788098,1.0,12/38,18.44%,SORBS1;IRS1;NCK1;LRRK2;SPAG9;AXIN1;SHANK3;SHANK2;CARD10;GRIP1;SH2B3;LDLRAP1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4328766297160612,0.9099349241401194,0.5993930197268589,1.0,1.0,2/10,8.00%,RENBP;GALE
prerank,GTPase inhibitor activity (GO:0005095),-0.33415013599263527,-0.9095247593944847,0.5910652920962199,0.9211053522034536,1.0,8/13,24.32%,SLIT2;TNK2;CPEB2;IPO5;IQGAP2;CDC42SE1;ARL2;RHOH
prerank,Wnt-activated receptor activity (GO:0042813),0.4017275798690332,0.9081864424250555,0.5834445927903872,1.0,1.0,2/15,4.16%,FZD9;FZD3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.34635568854500903,-0.9068754445954503,0.6025236593059937,0.9200230027049476,1.0,3/12,9.74%,SLC9A2;LETM1;SLC9B2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3787400826854608,0.9064525232663446,0.5765645805592543,1.0,1.0,6/18,21.54%,ANXA1;BAIAP2;RAB10;ANXA2;S100A11;PDLIM1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3449749412062518,0.9063629738719856,0.6203143893591294,1.0,1.0,9/34,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,protein heterodimerization activity (GO:0046982),0.2978862455055518,0.9062274845551078,0.6971830985915493,1.0,1.0,38/178,17.71%,LSM6;BAX;BMP6;USF1;XBP1;SAE1;FZD9;FBXO7;TENM3;TCF4;BARD1;ARNT;RRAGA;GTF2A2;ATP1A2;PEF1;BUD23;BDKRB2;DDIT3;SDCBP;YWHAH;PRMT5;KATNB1;TPM1;PIK3R2;BCL2;ADD2;RCC1;ZHX2;TENM4;TCF3;VAPB;AGTR1;FMR1;EXT2;MICU2;MTTP;QTRT2
prerank,alpha-tubulin binding (GO:0043014),0.34618985624768983,0.9055578758628731,0.6039360393603936,1.0,1.0,9/31,19.92%,ARL4C;TAOK1;DIP2B;OFD1;PACRG;ARL8B;DNAL1;DLEC1;INO80
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.34179369610563864,-0.9054509582804522,0.5746031746031746,0.9157388490310046,1.0,6/13,22.30%,SLC7A1;SLC7A6;SLC7A7;SLC15A4;SLC66A1;SLC38A5
prerank,ATPase binding (GO:0051117),0.3091065039514493,0.9054300360394999,0.630457933972311,1.0,1.0,12/71,12.68%,TMTC4;SELENOS;FBL;ATP6V0A2;SYVN1;ANK1;SNX10;BRSK2;ATP6V1G1;TCIRG1;PTPN3;ATP6V0A4
prerank,nuclear export signal receptor activity (GO:0005049),-0.3474373692113675,-0.9053065745177293,0.5964912280701754,0.9084389820039572,1.0,3/11,10.53%,EIF4ENIF1;XPO5;NUP42
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.324515773768071,-0.9047378490221628,0.5845070422535211,0.9022998946335792,1.0,6/15,12.36%,KMT2C;WDR82;RBBP5;SETD1B;SETD3;WDR5
prerank,N-methyltransferase activity (GO:0008170),0.37730740004882807,0.9043861521541554,0.6089743589743589,1.0,1.0,7/20,18.42%,DIMT1;NNMT;ZCCHC4;TRMT1;PRMT1;TFB1M;METTL5
prerank,methylation-dependent protein binding (GO:0140034),0.3204526887535042,0.9036858247761973,0.64293659621802,1.0,1.0,13/57,18.61%,CBX8;KDM7A;CHD8;PHF1;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.250617599708978,-0.9033228502513346,0.6666666666666666,0.8983117150504427,1.0,12/32,28.23%,SLC6A6;SLC3A2;SLC6A9;SFXN2;SLC36A4;SLC43A2;SLC38A5;SLC1A4;SFXN3;SLC36A1;SLC43A1;SLC6A7
prerank,tau protein binding (GO:0048156),0.3418124218979479,0.9031006360389271,0.6301531213191991,1.0,1.0,12/40,18.71%,BIN1;HSP90AA1;STUB1;TAOK1;CDK5;BRSK2;BRSK1;ROCK2;PPP5C;PPP2CB;APOE;PRKAA1
prerank,channel activity (GO:0015267),0.33295654253726653,0.9020618558902946,0.6204954954954955,1.0,1.0,4/41,14.55%,BAX;SLC14A1;BCL2;AQP4
prerank,cation channel activity (GO:0005261),0.3047475198513404,0.9017233710203268,0.6743455497382199,1.0,1.0,10/94,9.54%,PKD2L2;NALCN;SLC24A5;TMEM63A;GRIN1;TMEM63C;CALHM2;SLC24A4;TRPM3;KCNQ4
prerank,RNA stem-loop binding (GO:0035613),0.40930822202855444,0.9015637689145934,0.6070381231671554,1.0,1.0,5/12,16.79%,DDX3X;EPRS1;MYH10;RC3H2;FMR1
prerank,proton transmembrane transporter activity (GO:0015078),-0.24508045174154278,-0.9002717923303006,0.6546762589928058,0.8982485872822219,1.0,16/39,28.72%,SLC33A1;CLCN3;COX4I1;COX5A;COX8A;CTNS;NDUFA4;COX7A2L;COX6A1;DMAC2L;COX15;UQCR10;UQCRQ;UQCR11;NNT;COX5B
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4207412003190051,0.900200335571371,0.6115942028985507,1.0,1.0,3/12,14.45%,SULF1;ARSG;ARSB
prerank,cGMP binding (GO:0030553),-0.36225333365527534,-0.9001434128127171,0.6298701298701299,0.891240292024018,1.0,1/11,0.78%,PDE5A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.25812287648854293,-0.8996098311361188,0.6080402010050251,0.8849184229952243,1.0,11/29,22.72%,GABRB1;GABRG2;GABRA5;GLRA2;GABRA4;GRIK3;GRIN2D;GABRG1;GABRA1;GRIK4;GLRA3
prerank,adenyl ribonucleotide binding (GO:0032559),0.2944688790347126,0.8993379808135281,0.7847847847847848,1.0,1.0,64/291,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;PDE4A;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;GCLC;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;PDE10A;PDE4B;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,cell adhesion mediator activity (GO:0098631),0.36374313579721695,0.8988731496664687,0.606826801517067,1.0,1.0,8/24,20.32%,SIRPA;DSCAM;JAM3;CD47;NPTN;PLXNB3;CNTN2;NEXN
prerank,SUMO transferase activity (GO:0019789),0.3884452371292121,0.8980929322931522,0.6187150837988827,1.0,1.0,6/16,19.91%,HDAC4;PIAS3;TOPORS;MDM2;RANBP2;PIAS1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28979822451365034,0.8967740578834749,0.7555110220440882,1.0,1.0,52/248,18.76%,GPN2;ATL1;GBP3;DNM1;HSP90AA1;MYO19;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;KIF3C;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;ATP2B1;GNAS;DRG1;TOR1B;VCP;RHOBTB3;RAB3B;VPS4B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;ABCD2;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;DHX29;GNAQ;MRAS;RRAS2;RAB6A;ARL8B;KIF20B
prerank,ferrous iron binding (GO:0008198),0.3676328747670664,0.8966556826045537,0.6171352074966533,1.0,1.0,7/21,20.47%,ALKBH3;EGLN2;DNAJC24;HEPH;FTO;ALKBH1;FTH1
prerank,DNA binding (GO:0003677),0.28828197254451526,0.8965863338720499,0.858,1.0,1.0,130/694,18.36%,ILF3;CAMTA2;MMP12;POU6F1;SP7;APTX;DNASE1L2;MYRF;RNF138;HMGB3;NTHL1;ZEB2;CREBZF;USF1;NR2F2;AIFM2;ZNF8;XBP1;RORA;CARF;DDX3X;TAF4;MPG;CHD8;SDE2;POU2F1;RFX5;SLTM;FUBP1;CDK9;PALB2;TCF4;TCF7L2;TFCP2;FBH1;CNBP;IRF1;MLH1;SPO11;ABL1;DDB1;PHF1;ZNF35;TDP1;ZIC3;ARNT;RTF1;ZNF711;SMARCB1;TEAD1;SNAPC4;FANCG;TSHZ2;SOX9;DDIT3;XRCC6;KIN;DHX36;HDAC4;APLP2;ARID4A;CUL4B;RNF11;SAP30L;CALCOCO1;PSIP1;TOP1;DCLRE1A;KDM2B;APP;TAF6;RBPJ;ENDOV;BCL2;RC3H2;RPS15;IRF3;RBMS1;YY1;SMARCA1;E2F3;BRIP1;PARK7;SOX6;CEBPG;TDP2;PMS2;SETX;CBFB;CENPC;C1D;FOXJ3;MAPT;ZIC2;CAMTA1;BCL6;BCLAF1;ZNF292;XRN1;KMT2D;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;TCF3;NUPR1;SSBP2;FOXC2;HSPD1;SAFB2;BCLAF3;CLOCK;RAD50;CCNT1;TERF1;MBD1;THRAP3;SOX13;HP1BP3;TOPORS;NABP2;TOP3A;PCBP2;MEIS2;HMCES;RBBP8;MECP2;CUX1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.34158354888118564,0.8958711515254575,0.6104513064133017,1.0,1.0,11/34,20.73%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.34158354888118564,0.8958711515254575,0.6104513064133017,1.0,1.0,11/34,20.73%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,calcium:sodium antiporter activity (GO:0005432),0.4363534741548124,0.8958556009150344,0.6059701492537314,1.0,1.0,2/10,8.64%,SLC24A5;SLC24A4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.41533584161666753,0.8953607174881989,0.60932944606414,1.0,1.0,2/11,10.87%,RDH11;AKR1B10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.35681104833647204,-0.8947662346199955,0.5753846153846154,0.8893781505907669,1.0,10/11,64.34%,DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;DDAH1;PADI3;PADI6
prerank,ubiquitin protein ligase binding (GO:0031625),0.290493319317089,0.8941691611361505,0.7595190380761523,1.0,1.0,63/254,18.55%,UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,ligand-gated ion channel activity (GO:0015276),0.3438518361157058,0.8941426116577357,0.6151990349819059,1.0,1.0,5/30,14.10%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,SH3 domain binding (GO:0017124),-0.21207825543082925,-0.8920370450255569,0.6891891891891891,0.8891315626930204,1.0,12/62,12.25%,WASF2;CD2AP;DAB2IP;REPS1;SOCS7;AFAP1L2;SGIP1;PLSCR1;ABI2;ADAM15;VASP;SHANK3
prerank,protein homodimerization activity (GO:0042803),0.28810016657844156,0.8914412534760655,0.869,1.0,1.0,107/590,16.99%,TNNC1;XPNPEP3;LPL;CAMK2B;NQO2;BAX;TARBP2;CACYBP;DGCR8;GBP3;TSC2;CLN6;DCK;PIP4K2B;RAB11FIP4;HSP90AA1;RNF8;STUB1;PAXX;USF1;NR2F2;FGFR2;FGFR1;WARS1;ERP29;GLIPR2;MAD2L1;GLB1;FZD9;YARS2;ST3GAL2;PON3;SNF8;TKT;TENM3;MTCL1;SRGAP2;SRM;BARD1;SNX6;ARNT;ZBTB7B;RRAGA;GTF2A2;ZBTB38;ZDHHC3;HSD17B4;RAP1GAP;GALE;HM13;RDH5;DDIT3;TRIM9;EPRS1;RNF40;GNPTG;GDNF;TPM1;JUP;DPY30;PTH1R;BCL2;SARS1;PDGFRA;IRF3;ALS2;TARS2;CNOT9;CAMK2D;NUDT21;NACC2;CARNMT1;ENPP1;PARK7;VPS4B;CAMK2G;SOX6;STARD3;NPM1;ADD2;RACK1;HARS1;FBLN5;PIP4K2A;PEX7;PSAP;ZHX2;NRBP1;ACSL6;EPHX2;ABCB7;DNM1L;DPYD;TENM4;TCF3;VAPB;ABCD2;PRMT8;CHEK2;NUDT16L1;MAPK4;TERF1;TPPP;FMR1;ALDH3A2;STK25;EXT2
prerank,ligand-gated channel activity (GO:0022834),0.34559199905045995,0.8913324642901926,0.6198044009779952,1.0,1.0,5/29,14.10%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3886207067939056,0.8902871079809959,0.605890603085554,1.0,1.0,3/15,9.16%,HS2ST1;NDST2;HS6ST2
prerank,MAP kinase activity (GO:0004707),0.3920452012077874,0.8894958604181009,0.6080892608089261,1.0,1.0,3/14,16.36%,MAPK9;MAPK6;MAPK4
prerank,microtubule plus-end binding (GO:0051010),-0.2845321529323049,-0.8883628268346003,0.612,0.8905458003666775,1.0,5/20,13.15%,DST;CLIP1;MAPRE1;TTBK2;DCTN1
prerank,nuclear receptor binding (GO:0016922),0.29607047998033903,0.8871147265199812,0.7,1.0,1.0,35/111,22.79%,WBP2;MED24;SMARCD3;MED12;MED14;WIPI1;TCF7L2;MED13;TACC1;TGFB1I1;GAS2L1;MED4;PRPF6;YWHAH;BRD8;JUP;PARK7;TADA3;MMS19;DDX5;SNW1;TRIP4;DAXX;THRAP3;NSD1;NCOR2;PRMT2;NCOA3;TRIP12;SMAD3;TAF1;GTF2B;PKN1;MED17;NCOA1
prerank,actinin binding (GO:0042805),-0.2776983998778475,-0.8861273069976192,0.6238532110091743,0.8882706832739174,1.0,5/21,9.42%,CACNA1D;PDLIM5;CACNA1C;PROM1;RARA
prerank,transferrin receptor binding (GO:1990459),-0.35899046864759443,-0.8855880363517832,0.6142857142857143,0.8825181439159976,1.0,3/10,10.78%,IKBKB;SNX2;IKBKG
prerank,palmitoyltransferase activity (GO:0016409),-0.2540666573105366,-0.8833454789266606,0.6722222222222223,0.8805320539523391,1.0,12/28,26.75%,ZDHHC20;ZDHHC5;ZDHHC15;HHAT;GOLGA7;ZDHHC13;ZDHHC8;ZDHHC7;YKT6;ZDHHC16;ZDHHC4;ZDHHC24
prerank,metal ion:proton antiporter activity (GO:0051139),-0.33027013362526003,-0.8822342152014477,0.6396103896103896,0.8762198888202595,1.0,3/13,9.74%,SLC9A2;LETM1;SLC9B2
prerank,cytokine receptor binding (GO:0005126),0.30408519584667243,0.88141528445397,0.6817702845100105,1.0,1.0,19/83,24.48%,IL34;DDT;CXCL12;IL22;PIBF1;SDCBP;PRLR;USP15;PXDN;IL1RAP;CCL25;JAK1;TGFBR3;SMAD2;SMAD3;IL18;FKBP1A;JAK2;TRAF6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2845999141636671,0.8806824275561762,0.859,1.0,1.0,93/431,19.61%,ARL4C;STK36;GNL3;ATL1;GBP3;PIP4K2B;HSP90AA1;GALK1;RAC1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;DRG2;TUBB2A;ABL1;CARS1;SARS2;GBP7;STK11;N4BP2;RRAGA;BRSK2;TARS1;RAP2A;RHOD;ATP1A2;AARS1;TUBD1;SIK1;TUBA1A;DHX36;DRG1;RAB10;ARL5B;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;DYNC1LI1;TLK1;ENPP1;ABCF2;HARS1;RAB13;PRKCI;DAPK1;AK6;TUBA1B;BMS1;GBP6;TUBB;RAB31;PPP5C;ACVR1B;ABCD2;RAB8A;SYN2;MTG2;RIT2;MLKL;OAS2;RAB21;OXSR1;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;RABL6;MTPAP;CDK11B
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4185005686888192,0.8806316179258104,0.6297935103244838,1.0,1.0,2/10,14.64%,DPP9;DPP10
prerank,kinase binding (GO:0019900),0.2852237470073074,0.8799162799534869,0.837,1.0,1.0,87/435,17.12%,CDKN2D;TNNI3;UBQLN1;CENPJ;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;RAC1;STUB1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;IL31RA;NEFH;SNAI1;NEK9;FBXO7;CARD16;TCF7L2;ERRFI1;DLG3;SQSTM1;THY1;FBXO5;BARD1;ARHGEF7;DVL1;RHOD;RFFL;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;GPRC5B;PER1;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;CNOT9;IQGAP1;PARK7;NPM1;HNRNPA0;LRRC14;ADD2;SUFU;VDAC1;TNS2;PTPN22;EMP2;PARP16;HTT;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;DLG2;SPRY2;OXSR1
prerank,pyrophosphatase activity (GO:0016462),0.3162140373527101,0.8780928087487284,0.6685584562996595,1.0,1.0,12/50,18.34%,DDX3X;ENTPD7;PPA2;PRUNE1;NUDT3;BNIP2;ENPP1;PLPP4;PLPP5;NUDT16L1;DHX29;ATCAY
prerank,N-acyltransferase activity (GO:0016410),0.3338979423242598,0.8740021961384868,0.6462093862815884,1.0,1.0,5/32,12.73%,SIRT7;CERS2;GNPNAT1;NMT1;TLCD3B
prerank,galactosyltransferase activity (GO:0008378),0.4077296234013499,0.8731520079772536,0.663235294117647,1.0,1.0,2/11,12.71%,A4GALT;B4GALT5
prerank,Hsp70 protein binding (GO:0030544),0.3328376600769922,0.8722985334715672,0.6662621359223301,1.0,1.0,9/31,23.86%,IQCG;STUB1;GPR37;DNAJC10;PACRG;RPS3;DNAJC2;DNAJB12;TSC1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2808251174309221,-0.8720731806228831,0.6359832635983264,0.8923329357015216,1.0,17/21,62.74%,CHRNA7;GLRB;P2RX7;CHRNB1;P2RX4;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1
prerank,cholesterol transfer activity (GO:0120020),-0.30968602751983865,-0.8716149684587624,0.6007751937984496,0.8868081681546784,1.0,3/16,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.25849509779319385,-0.8709958057350539,0.675,0.8814872264044916,1.0,8/28,21.64%,GABRG2;GABRA5;CHRNA7;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,Hsp90 protein binding (GO:0051879),0.3318539156811411,0.869225288752401,0.6666666666666666,1.0,1.0,12/33,21.94%,UNC45A;TSC2;STUB1;STIP1;USP19;MAPT;PPP5C;CHORDC1;PACRG;RPS3;NPAS2;TELO2
prerank,beta-tubulin binding (GO:0048487),0.3328729869034012,0.8690709800553663,0.6552567237163814,1.0,1.0,12/31,23.60%,TAOK1;GJB6;HTT;VAPB;TBCD;PACRG;ARL8B;PDCD5;DLEC1;FGF13;TTLL7;EML4
prerank,protein serine/threonine kinase activity (GO:0004674),0.28176518179884324,0.8683092824048155,0.834,1.0,1.0,86/335,21.36%,MAPK9;CAMK2B;CAMK1G;STK36;ARAF;PDPK1;CSNK2A2;MAP3K14;EIF2AK3;DMPK;CDKL5;CASK;HUNK;TAOK1;HTATIP2;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;BRD4;NUAK1;SQSTM1;PAK3;STK11;BRSK2;KALRN;SBK1;SIK1;CIT;FAM20C;NRBP2;WNK2;TOP1;BRSK1;GRK3;MAPK6;CAMK2D;TLK1;CAMK2G;ATR;RPS6KA3;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;GRK2;CSNK1A1;ACVR1B;RPS6KA1;TRIO;CHEK2;MAP3K1;MAPK4;CAMK1D;TP53RK;CLK4;CDK7;OXSR1;ILK;PRKD2;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;PTK2B;MAPKAPK2;PAK5;ACVR2A;SGK3;MAP4K4;STK35;SMG1
prerank,motor activity (GO:0003774),-0.2133917223278543,-0.8671407126217873,0.7945205479452054,0.8835839333290311,1.0,23/60,31.84%,KIF13B;KIF26B;MYL6;KLC1;KIF1C;KIF13A;MYO6;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23
prerank,GTP binding (GO:0005525),0.28259903994633573,0.8661196558417047,0.7706422018348624,1.0,1.0,35/172,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;TUBD1;TUBA1A;DRG1;RAB10;ARL5B;RHOBTB3;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,low-density lipoprotein particle binding (GO:0030169),-0.29423450279802515,-0.8659644210031896,0.6821705426356589,0.8797931965319242,1.0,4/16,22.44%,SCARB1;THBS1;SCARF1;STAB1
prerank,phosphatidic acid binding (GO:0070300),0.37119813587085676,0.8656151035004109,0.6631016042780749,1.0,1.0,2/19,2.84%,GSDMD;PLEKHN1
prerank,voltage-gated chloride channel activity (GO:0005247),0.4127519044042247,0.8643376071879779,0.6641901931649331,1.0,1.0,2/10,8.19%,CLCN2;CLCN4
prerank,single-stranded telomeric DNA binding (GO:0043047),0.406157941617563,0.8627984694207543,0.6329305135951662,1.0,1.0,5/11,18.57%,HNRNPA2B1;RAD50;TERF1;NABP2;TERF2IP
prerank,guanyl ribonucleotide binding (GO:0032561),0.2796255101692499,0.8612207555110285,0.7880928355196771,1.0,1.0,40/196,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;RAB12;TUBD1;TUBA1A;RAB5B;DRG1;RAB10;ARL5B;RHOBTB3;RAB3B;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;PDE10A;RAB8B;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,phospholipid transfer activity (GO:0120014),-0.27062054325384655,-0.8601666798932086,0.6798245614035088,0.8850234349453185,1.0,4/21,5.50%,OSBPL2;PITPNA;CERT1;PITPNC1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3000977027886792,0.8598931400960639,0.698093220338983,1.0,1.0,12/71,13.92%,DUSP18;ACP1;PTPRN;DUSP26;CDC14B;CDC25A;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2
prerank,single-stranded DNA binding (GO:0003697),0.2936507126724024,0.8596902116844751,0.7343915343915344,1.0,1.0,25/93,20.54%,APTX;RNF138;FUBP1;FBH1;MLH1;TDP1;RTF1;DHX36;TOP1;RBMS1;PARK7;TDP2;PMS2;MAPT;NUCKS1;SSBP2;HSPD1;NABP2;TOP3A;PCBP2;HMCES;RBBP8;NUP35;HNRNPU;SUB1
prerank,tRNA binding (GO:0000049),-0.22569422593435626,-0.8592444418173361,0.734375,0.8803036929166873,1.0,15/43,18.56%,EIF2AK4;EIF2A;XPOT;MRPS27;NSUN6;TRNAU1AP;AIMP1;DARS2;EEF1A1;TRNT1;TYW5;NAT10;ELP5;DALRD3;TRMT10B
prerank,manganese ion binding (GO:0030145),0.3099568636664482,0.8570010166972207,0.6824480369515011,1.0,1.0,12/48,21.34%,XPNPEP3;GALNT4;ABL1;POMGNT1;FAM20C;SOD2;TDP2;PPM1M;MTPAP;IMPA1;EXD2;ME1
prerank,general transcription initiation factor binding (GO:0140296),-0.25878760354020314,-0.8567949874374047,0.7236180904522613,0.8788033407632193,1.0,11/25,23.64%,THRA;AR;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,lysophospholipase activity (GO:0004622),0.35050531335910134,0.8527545830041425,0.6604774535809018,1.0,1.0,6/20,20.14%,LYPLAL1;GDPD3;ENPP2;PNPLA7;GDE1;ABHD16A
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.40646629988097754,0.8505518360233837,0.6778115501519757,1.0,1.0,5/10,19.44%,EHMT2;SUV39H1;EHMT1;ASH1L;SETD5
prerank,telomerase RNA binding (GO:0070034),0.3523061603666466,0.8502798877260237,0.6585365853658537,1.0,1.0,6/22,20.48%,NHP2;WRAP53;DHX36;XRN1;SMG7;HNRNPU
prerank,insulin-like growth factor I binding (GO:0031994),-0.31701677783077065,-0.8492363792882556,0.6807817589576547,0.8881581578467924,1.0,2/13,2.38%,IGF1R;ITGA6
prerank,histone methyltransferase binding (GO:1990226),0.4017746601529323,0.8489994260302997,0.6690751445086706,1.0,1.0,2/11,6.32%,NOP56;PHF1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2582096565028141,-0.8487570791990988,0.7105263157894737,0.8827494926321362,1.0,11/27,32.09%,SLC9A2;SLC3A2;SLC8B1;SLC9B2;SLC4A8;SLC9A8;KCNK1;CNNM4;SLC8A1;SLC9A5;SLC8A2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.27659573423765454,0.847582508283609,0.8418418418418419,1.0,1.0,35/254,12.60%,HSF2;SP7;NFKB1;SMARCD3;MLXIP;NKX2-2;GLIS2;STAT6;TFDP1;NFKB2;RFX5;TCF4;TFCP2;IRF1;ZIC3;CASZ1;DBP;SOX9;SMARCD1;DDIT3;MDM4;ATMIN;SOX11;PRRX1;NKRF;ATF2;ZNF445;RBPJ;RFX4;NFAT5;IRF3;YY1;E2F3;CEBPG;CREB3
prerank,glycine binding (GO:0016594),0.3913177673381381,0.847170709817769,0.6638054363376252,1.0,1.0,2/11,14.46%,GRIN1;GLRA1
prerank,CoA hydrolase activity (GO:0016289),0.3680340996635213,0.8462953942867953,0.6647646219686163,1.0,1.0,2/16,5.66%,ACOT9;ACOT11
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.27770473707986154,0.8453431869242994,0.7845528455284553,1.0,1.0,34/147,16.51%,SH3BP5;NUCB2;ARHGEF10;GAPVD1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;KALRN;MYCBP2;DOCK8;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;VAV2;DENND4C;DENND5A;RIC8B;ALS2;MON1A;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;EEF1B2;CYTH1;FARP2;DNMBP;ARHGEF6;EPS8L1;DENND6A
prerank,histone demethylase activity (GO:0032452),0.33037773171549023,0.8445771082356436,0.6724565756823822,1.0,1.0,7/27,19.43%,KDM4D;KDM7A;JARID2;KDM2B;KDM6B;KDM3B;KDM6A
prerank,protein kinase binding (GO:0019901),0.2725282433931282,0.8443546948610391,0.91,1.0,1.0,93/480,18.28%,CDKN2D;TNNI3;CENPJ;DACT2;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;HSP90AA1;RAC1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;PICK1;NELL1;TIRAP;IL31RA;NEFH;NEK9;FBXO7;TCF7L2;ERRFI1;ABL1;SQSTM1;THY1;FBXO5;ARHGEF7;DVL1;RHOD;RFFL;HDAC5;SIRPA;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;SOX9;GPRC5B;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;YWHAG;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;IQGAP1;NPM1;MAPK8IP3;HNRNPA0;ADD2;RACK1;ROR2;SUFU;VDAC1;EMP2;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;TCF3;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;SPRY2;OXSR1;TNIP1;CAMK2N1;ILK;PRKD2;RELB;CCDC88A;PRKAR1A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2790172941939407,0.8433342960829198,0.8253012048192772,1.0,1.0,47/188,22.16%,ZBTB48;NFKB1;ZNF568;CREBZF;GLIS2;PSPC1;MTERF3;TCF7L2;IRF1;TBP;HDAC5;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;CALCOCO1;ZBTB20;SUV39H1;YY1;SOX6;HNRNPL;SMAD6;SOX5;KMT2D;RFX3;FOXC2;SOX13;TCF7;GABPB1;GABPB2;TBL1XR1;NONO;SOX4;KLF4;CARM1;GABPA;CTCF;TAF2;CREB3L2;HMGB1;ZBED4;SMAD3;ERBB4
prerank,neurexin family protein binding (GO:0042043),0.4040347600108358,0.8415599296073131,0.6750369276218612,1.0,1.0,3/10,19.84%,NLGN3;NLGN2;SYTL2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.3888331258204861,0.8392389147413116,0.6700879765395894,1.0,1.0,2/11,4.91%,RPH3A;ITPR1
prerank,"DNA binding, bending (GO:0008301)",0.37222248681590175,0.8385229979632264,0.6788218793828892,1.0,1.0,5/14,22.00%,HMGB3;SAP30L;TERF1;FOXD1;HMGB1
prerank,phosphotyrosine residue binding (GO:0001784),0.3184681669276608,0.8381253922958521,0.7105575326215896,1.0,1.0,7/37,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,cAMP binding (GO:0030552),0.39577289773469604,0.8369166947312792,0.680635838150289,1.0,1.0,3/11,15.76%,PDE4A;PDE10A;PDE4B
prerank,ligand-gated cation channel activity (GO:0099094),0.2873978065301983,0.8349554461117761,0.7414529914529915,1.0,1.0,7/75,14.10%,ASIC1;GRIN1;GRIK5;KCNJ10;GRIN2A;GRIA1;GRIA2
prerank,protein tyrosine kinase binding (GO:1990782),0.2895016452725886,0.834623387183121,0.740343347639485,1.0,1.0,12/71,14.97%,HSP90AA1;SQSTM1;SIRPA;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.38608826668340784,0.8328991555696786,0.6767241379310345,1.0,1.0,12/12,61.42%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW3;OPN1MW;RRH;GPR52;GPR88;OPN3
prerank,adenylyltransferase activity (GO:0070566),0.343301074449462,0.8321591252845524,0.709043250327654,1.0,1.0,10/21,26.89%,ABL1;FLAD1;COASY;OAS2;MTPAP;SELENOO;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,ion gated channel activity (GO:0022839),0.3322677181093798,0.8307642575827722,0.6996291718170581,1.0,1.0,4/24,12.53%,TMEM63A;KCNT2;TMEM63C;TTYH2
prerank,actin monomer binding (GO:0003785),0.34307603643679274,0.8279632734091353,0.6994818652849741,1.0,1.0,3/22,6.07%,ABITRAM;MRTFA;ABL1
prerank,lysine N-methyltransferase activity (GO:0016278),0.345092192630123,0.8274546799119554,0.7087765957446809,1.0,1.0,5/20,15.49%,ETFBKMT;SETD7;EHMT2;EHMT1;ATPSCKMT
prerank,solute:anion antiporter activity (GO:0140323),0.35938445490958226,0.8253697294316555,0.6792717086834734,1.0,1.0,1/14,1.47%,SLC7A11
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.2964369824549057,0.8252671625639583,0.7480136208853575,1.0,1.0,8/48,18.02%,NALCN;MMGT1;CALHM2;SLC39A1;TRPM3;SLC41A1;ATP6V1B2;PKD2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.287501647908738,0.8252654144875221,0.7810526315789473,0.9975461958727522,1.0,27/91,23.33%,GSDMD;RPH3A;WIPI1;TIRAP;SNX14;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;MAPT;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;KCNH1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18;WIPI2;SYT7;SH3PXD2B
prerank,sodium channel activity (GO:0005272),0.30893619449091486,0.8245980428674626,0.699885452462772,0.9960641362105019,1.0,4/37,10.99%,ASIC1;SCN7A;GRIK5;SCN1A
prerank,SH2 domain binding (GO:0042169),0.31570797158012764,0.8227120739369748,0.7268292682926829,0.9966766258932556,1.0,12/31,24.20%,ABL1;SQSTM1;DAG1;RACK1;BLNK;RUFY1;AFAP1;CCDC88A;DLC1;SH3PXD2B;KHDRBS1;JAK2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.31641288495645414,0.8218264565907907,0.717852684144819,0.9956209813009904,1.0,8/30,18.90%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5;SLC25A37;SLC11A2
prerank,DNA polymerase binding (GO:0070182),-0.27003097708479573,-0.8216132139415359,0.7899159663865546,0.9313778315131922,1.0,9/18,26.42%,PTGES3;HSP90AB1;NAT10;SMG6;RTEL1;FANCI;CDK2AP1;POLG2;PCNA
prerank,chemoattractant activity (GO:0042056),0.32057069405238287,0.8213874229372434,0.7236180904522613,0.9936387923531114,1.0,3/26,10.19%,NTF3;FGF10;GDNF
prerank,DNA secondary structure binding (GO:0000217),0.3142095649268135,0.8207996712609161,0.7324290998766955,0.9920290460461746,1.0,10/31,22.00%,XRCC2;HMGB3;ABL1;FANCM;YY1;MAPT;RBBP8;KMT2A;RAD18;HMGB1
prerank,telomeric DNA binding (GO:0042162),0.31055722764627164,0.8147802333089529,0.7364532019704434,0.999267345385339,1.0,11/32,21.94%,ZBTB48;XRCC6;HNRNPD;HNRNPA2B1;RAD50;TERF1;UPF2;SMG7;TERF2IP;SMG1;TELO2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2877354757202865,0.8101410117277189,0.7676438653637351,1.0,1.0,21/60,24.09%,PPM1B;CDC14B;PPP1CC;PPM1H;CTDSPL2;CAMK2G;PPM1E;CTDSP2;PPP5C;PPM1M;PPP2CB;TAB1;PHLPP2;PPP4C;PPM1A;LRRK1;PPM1F;RPAP2;PTEN;PPP3CB;PPM1D
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.24825399211207966,-0.8101191385812896,0.8040201005025126,0.9468198940399656,1.0,7/26,17.61%,PPME1;PPP1R1A;ENSA;PPP1R14C;LMTK2;PPP1R8;BOD1L1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.264177096180509,-0.8094432377706584,0.7336065573770492,0.9415291317700213,1.0,7/19,21.64%,GABRG2;GABRA5;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,microtubule motor activity (GO:0003777),-0.2017227506748976,-0.8089782994915179,0.8947368421052632,0.9358743394413561,1.0,27/51,38.91%,KIF13B;KIF26B;KIF1C;KIF13A;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23;KIF11;KIF1B;KIF15;KIF21B;KIF17;CENPE;DNAH3
prerank,sterol transfer activity (GO:0120015),-0.28296861611094254,-0.8074785812313423,0.752,0.9321633192051287,1.0,3/17,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,snoRNA binding (GO:0030515),0.31252010270383257,0.80614767830253,0.7460701330108828,1.0,1.0,2/30,3.94%,NHP2;NOP56
prerank,endopeptidase regulator activity (GO:0061135),0.305974116212189,0.802924138065,0.7749120750293084,1.0,1.0,5/40,12.13%,USP14;ABCA2;RENBP;PSME2;TFPI
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.33039924131225284,-0.7992116330104371,0.7168141592920354,0.9412202695727957,1.0,4/10,13.99%,SETD2;NSD2;SETD3;SMYD2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.28262242428444034,0.7986584627732418,0.8021505376344086,1.0,1.0,20/72,22.30%,GSDMD;RPH3A;TIRAP;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2995018648597688,0.7983229539838032,0.7432905484247374,1.0,1.0,8/34,15.49%,ETFBKMT;SETD7;EZH2;EHMT2;NSD3;SUV39H1;EHMT1;ATPSCKMT
prerank,peptidoglycan binding (GO:0042834),-0.3286717123110736,-0.7976473694279115,0.7392550143266475,0.937523372536167,1.0,2/10,4.72%,HK1;NOD1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2978720729598453,0.7963412164328917,0.7577497129735936,1.0,1.0,7/42,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.29696978641798705,-0.7943894234481299,0.7401812688821753,0.9370565747959201,1.0,5/12,19.85%,NUDT5;ENTPD1;ENTPD6;SLC25A42;CANT1
prerank,3'-5' DNA helicase activity (GO:0043138),0.34689564704744225,0.7930989804079844,0.7196132596685083,1.0,1.0,3/16,11.56%,HELQ;FBH1;FANCM
prerank,double-stranded DNA binding (GO:0003690),0.2547143717729492,0.7929193275043438,0.978,1.0,1.0,98/531,22.00%,CAMTA2;HSF2;POU6F1;ZNF23;APTX;ZBTB48;HMGB3;PKNOX2;NTHL1;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;RFX5;SNAI1;TCF4;TFCP2;FBH1;ZNF276;ABL1;TDP1;ZIC3;ARNT;ZBTB7B;TEAD1;ZNF32;DBP;SOX9;XRCC6;KIN;LIN28B;PSIP1;HOXB8;ATF2;TOP1;ZBTB20;ZNF445;GLIS1;RFX4;BACH2;NFAT5;IRF3;RBMS1;YY1;E2F3;NFIX;PARK7;CEBPG;CREB3;CREB3L4;FOXJ3;MAPT;ESRRG;CAMTA1;BCL6;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;HOXC8;CLOCK;RAD50;TERF1;MBD1;OSR1;TCF7;MEIS2;ZNF177;RBBP8;MECP2;CUX1;BCL11B;KLF13;SOX4;ZIC4;RPS3;KLF4;GABPA;PKNOX1;HNRNPU;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;NPAS2;SMAD2;ETV3;MSH3;HMGB1
prerank,peptidase inhibitor activity (GO:0030414),0.30619574810509687,0.7920614703159456,0.7514654161781946,1.0,1.0,6/33,19.60%,USP14;RENBP;TFPI;SERPIND1;TIMP2;PROS1
prerank,antiporter activity (GO:0015297),0.3299933084650316,0.7916496211720209,0.75,1.0,1.0,3/20,8.19%,SLC35D2;ATP1A3;CLCN4
prerank,endonuclease activity (GO:0004519),0.28798481552483685,0.79107221475387,0.7835738068812431,1.0,1.0,10/49,17.10%,NTHL1;APLF;LACTB2;N4BP2;RCL1;CPSF3;AGO3;SND1;MRE11;ZC3H12C
prerank,phosphatidylinositol binding (GO:0035091),0.27007819637230934,0.7910074579797296,0.8194154488517745,1.0,1.0,21/91,18.25%,PLEKHN1;RPH3A;SNX5;ITPR1;PIGU;THY1;SNX10;SNX24;SNX11;PIGK;MAPT;TULP3;NUMA1;SNAP91;DPEP1;PARD3B;SNX4;PITPNM2;PHF12;CCDC88A;ZFYVE16
prerank,glutamate receptor binding (GO:0035254),0.33703753208220383,0.7897216141870066,0.730820995962315,1.0,1.0,5/17,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,DNA-binding transcription factor binding (GO:0140297),0.259451874045633,0.7862188786913203,0.8946840521564694,1.0,1.0,47/189,22.40%,TEAD3;DUSP26;BBS10;CRTC1;USF1;MIER2;TCF7L2;BBS7;TBP;HDAC5;SIK1;DDIT3;CRTC3;TTC8;HDAC4;TWIST1;PRRX1;RBL2;ATF2;PSMC5;RBPJ;BCL2;MTA2;PARK7;NPM1;HDAC1;RUNX1T1;PIAS3;TCF3;CTBP1;CBX5;MTDH;TLE5;RBBP8;ATN1;KLF4;GABPA;PIAS1;MIER1;SMAD2;TCERG1;HMGB1;SMAD3;MTA1;TAF1;IFI27;ID2
prerank,sequence-specific DNA binding (GO:0043565),0.2520478693107852,0.7849270567603623,0.983,1.0,1.0,112/590,22.21%,MMP12;HSF2;POU6F1;ZNF23;MYRF;PKNOX2;ZEB2;USF1;NR2F2;TEF;MAFG;GLIS2;NR1D2;XBP1;RORA;KMT2B;NFKB2;POU2F1;RFX5;SNAI1;SLTM;TCF4;TCF7L2;TFCP2;ZNF276;ABL1;ZNF35;ZIC3;ARNT;ZBTB7B;ZNF711;TEAD1;ZNF32;ZBTB38;DBP;SOX9;XRCC6;HNRNPD;PRMT5;HDAC4;LIN28B;CALCOCO1;HOXB8;ATF2;ZBTB20;KDM2B;RBPJ;GLIS1;RFX4;BCL2;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;CEBPG;CREB3;CREB3L4;PRMT1;CBFB;FOXJ3;MAPT;ESRRG;BCL6;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;SAFB2;HOXC8;CLOCK;TERF1;UPF2;MBD1;SOX13;OSR1;TCF7;MEIS2;ZNF177;SMG7;MECP2;CUX1;KMT2A;BCL11B;TERF2IP;FOXD1;KLF13;SOX4;ZIC4;TET1;KLF4;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;SMG1;NPAS2;FOXO1;ETV3;TELO2;SMAD3;TAF1;HOXA7
prerank,glutamate receptor activity (GO:0008066),-0.2573758858400597,-0.7823135635643576,0.809322033898305,0.9507816159614643,1.0,3/19,4.76%,GRM7;GRM1;GRM3
prerank,tau-protein kinase activity (GO:0050321),0.3270774145892323,0.781861889441349,0.7571059431524548,1.0,1.0,5/20,14.18%,TAOK1;CDK5;BRSK2;BRSK1;ROCK2
prerank,Notch binding (GO:0005112),0.31387398776815106,0.7810988315667058,0.7772020725388601,1.0,1.0,5/22,18.66%,TCIM;SNW1;JAG1;SNED1;NCOR2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2987279774303187,0.7766433626984918,0.7949640287769785,1.0,1.0,14/33,24.48%,AUP1;PARK7;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5;RPS3;TCERG1;UBA2;SIAH2;TRAF6
prerank,RNA polymerase binding (GO:0070063),0.33233757532931557,0.7748124380443245,0.7664041994750657,1.0,1.0,6/18,21.94%,BIN1;PPIB;CCNT1;YTHDC2;CCNT2;TCERG1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.310103082659151,-0.7730624118507664,0.7181008902077152,0.9596294008647313,1.0,5/10,20.78%,STAMBPL1;CYLD;STAMBP;OTUD4;OTUD5
prerank,nuclear import signal receptor activity (GO:0061608),0.3357308749971144,0.7687269701211145,0.754874651810585,1.0,1.0,4/15,18.71%,KPNA3;KPNB1;TNPO1;KPNA1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.24189675233289645,-0.7686584040447539,0.8416666666666667,0.9479667510405438,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.24189675233289645,-0.7686584040447539,0.8416666666666667,0.9479667510405438,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,serotonin receptor activity (GO:0099589),-0.24189675233289645,-0.7686584040447539,0.8416666666666667,0.9479667510405438,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.30023794322622777,-0.7674376319596496,0.7574850299401198,0.9435839022003322,1.0,4/11,9.10%,UBE2K;RBX1;AMFR;UBOX5
prerank,calcium-activated potassium channel activity (GO:0015269),0.35991424851032094,0.7673701363490175,0.7549467275494672,1.0,1.0,1/11,6.83%,KCNMA1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.27859955852933344,0.7672628535565467,0.8145620022753128,1.0,1.0,14/44,19.65%,KMT2B;SETD7;EZH2;EHMT2;SETD1A;NSD3;SUV39H1;EHMT1;KMT2D;ASH1L;NSD1;KMT2A;SETD5;KMT5B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30360830318750603,0.7654975545135222,0.7776412776412777,1.0,1.0,8/27,17.92%,AUP1;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.27167855507276595,0.7624254092402415,0.8119469026548672,1.0,1.0,7/57,9.77%,UQCRC1;NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3665186223766364,0.7617169058118631,0.7797356828193832,1.0,1.0,2/10,10.31%,CACNB4;CACNB1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.24491461432379166,0.7609546611808061,0.993,1.0,1.0,113/597,22.21%,HSF2;POU6F1;ZNF23;ZBTB48;NFKB1;ZNF568;PKNOX2;CREBZF;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;PSPC1;RFX5;SNAI1;MTERF3;TCF4;TCF7L2;TFCP2;ZNF276;IRF1;TBP;ABL1;ZIC3;ARNT;ZBTB7B;DHX33;TEAD1;HDAC5;ZNF32;DBP;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;LIN28B;SOX11;CALCOCO1;HOXB8;ATF2;ZBTB20;GLIS1;RFX4;SUV39H1;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;SOX6;CEBPG;CREB3;CREB3L4;HNRNPL;CENPC;FOXJ3;ESRRG;BCL6;SMAD6;SOX5;KMT2D;RFX3;NR2C2;TCF7L1;FOXC2;HSPD1;MAF;HOXC8;CLOCK;SOX13;OSR1;TCF7;GABPB1;GABPB2;MEIS2;TBL1XR1;ZNF177;CUX1;BCL11B;NONO;KLF13;SOX4;ZIC4;ZW10;KLF4;CARM1;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;TAF2;NFATC3;CREB3L2;FOXJ2;GLI3;NPAS2;ETV3;HMGB1;ZBED4;SMAD3;ERBB4;HOXA7
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2572289874774609,0.7569143733487721,0.8795430944963655,1.0,1.0,15/100,13.93%,GSDMD;PLEKHN1;RPH3A;WIPI1;OGT;MYO1B;PLEKHA3;SNX24;ATG2A;SAP30L;ADAP2;IQGAP1;ARAP1;SNX11;MAPT
prerank,carboxypeptidase activity (GO:0004180),0.2883914672684947,0.7539490585308474,0.793144208037825,1.0,1.0,6/35,16.08%,CPXM1;AGBL3;PEPD;CPXM2;CTSZ;AGBL4
prerank,myosin V binding (GO:0031489),0.32875833012448835,0.7532791389108411,0.7771739130434783,1.0,1.0,6/15,25.35%,RAB10;RAB3B;RAB8A;RAB6A;RAB11B;RAB11A
prerank,calcium-release channel activity (GO:0015278),0.3213949984858354,0.7514064997711317,0.7738896366083445,1.0,1.0,4/17,18.02%,ITPR1;TPCN1;RASA3;PKD2
prerank,WW domain binding (GO:0050699),0.29925873089857924,0.7506640930257751,0.8073170731707318,1.0,1.0,2/26,4.74%,TCEAL5;PMEPA1
prerank,R-SMAD binding (GO:0070412),0.3166740555895286,0.7495235701812181,0.7757496740547588,1.0,1.0,8/18,22.11%,PMEPA1;SMAD6;DDX5;SMURF1;RANBP3;PPM1A;SMAD2;SMAD3
prerank,gap junction channel activity (GO:0005243),0.3039884059618727,0.748190020820823,0.7919896640826873,1.0,1.0,2/22,9.65%,GJB2;GJB6
prerank,wide pore channel activity (GO:0022829),0.30098855833775107,0.7479827816186646,0.7821656050955414,1.0,1.0,2/23,9.65%,GJB2;GJB6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34078937939952697,0.747335621462045,0.7779390420899854,1.0,1.0,6/12,24.60%,PIK3CB;PIK3C2B;PIK3C3;IPMK;ATM;PIK3C2A
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3386618682199157,0.7464640379841194,0.7762430939226519,1.0,1.0,3/14,19.25%,SPOCK1;SPOCK2;TIMP2
prerank,SUMO binding (GO:0032183),-0.2695956434200975,-0.745439658897008,0.8085808580858086,0.9695750064755225,1.0,5/13,19.97%,CASP8AP2;PML;TDG;HABP4;CBX4
prerank,heme binding (GO:0020037),0.25788796883001036,0.74396725609565,0.8449023861171366,1.0,1.0,8/65,14.59%,DGCR8;CYP27A1;RSAD1;BACH1;CYP26B1;CYP51A1;PTGS2;PXDN
prerank,tRNA methyltransferase activity (GO:0008175),0.3220809212381701,0.743961891591151,0.815068493150685,1.0,1.0,3/16,12.90%,TRDMT1;METTL2B;METTL2A
prerank,insulin-like growth factor binding (GO:0005520),-0.26522334999489733,-0.7432065380927906,0.82,0.9667015093204098,1.0,2/15,2.38%,IGF1R;ITGA6
prerank,protein phosphatase binding (GO:0019903),0.24646390091745943,0.7423177531292531,0.8855359001040582,1.0,1.0,32/117,22.66%,EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;SIRPA;PPP1R9B;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;RACK1;ANAPC4;PPP1R16A;MAPT;STX17;MTMR4;PPP1R11;JAK1;SMG7;ANAPC5;ARPP19;KIFAP3;IGBP1;ATP2B4;FOXO1;TRAF2;ITGA1;MAP2K7
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.32552154970866976,0.7423104155843736,0.7808988764044944,1.0,1.0,4/14,19.20%,USP7;USP15;USP9X;YOD1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.34520104525342127,0.740680644859798,0.7651403249630724,1.0,1.0,3/11,17.75%,PPP1R2;PPP1R14A;PPP1R11
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.21220678233252424,-0.7369255257449694,0.8686868686868687,0.9690577261264522,1.0,17/27,36.71%,POLR3B;TENT2;POLR3A;CRCP;MED20;POLR1F;POLR3H;TERT;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,glucuronosyltransferase activity (GO:0015020),0.3026083587080206,0.7365711965165428,0.8129205921938089,1.0,1.0,1/19,3.69%,CHPF
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.21462835305484046,-0.7359629669899643,0.8817733990147784,0.9642066911126574,1.0,9/29,20.16%,SIRT1;NFATC1;NBR1;DUSP10;PTPRJ;ACE;MAPKAPK3;DUSP1;GCH1
prerank,solute:proton symporter activity (GO:0015295),0.3152555890639935,0.7321662505939958,0.8131868131868132,1.0,1.0,1/16,0.83%,SLC17A5
prerank,regulatory RNA binding (GO:0061980),0.2724197655625427,0.7314189010352742,0.8484136310223267,1.0,1.0,10/38,22.97%,TARBP2;ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.31425759472934894,0.7310529721912331,0.8073770491803278,1.0,1.0,4/17,15.15%,BLVRB;BLVRA;MECR;DPYD
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.28446571419760835,-0.7305867089491461,0.8140243902439024,0.9653835545662554,1.0,7/10,32.98%,DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3255406204057578,0.7292151851660709,0.8254189944134078,1.0,1.0,2/14,4.86%,ISCA2;RSAD1
prerank,DNA polymerase activity (GO:0034061),-0.2280172943515483,-0.7284214041480478,0.9150943396226415,0.9620058678196418,1.0,10/22,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;TERT;POLE2;POLQ;POLK;POLI
prerank,store-operated calcium channel activity (GO:0015279),0.3445661234159723,0.7276110009869216,0.7928464977645305,1.0,1.0,1/10,2.25%,ORAI2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.26462415785213383,0.727048329056203,0.8555176336746303,1.0,1.0,7/47,16.34%,SLC7A11;SLC22A4;SLC38A9;SLC7A2;SLC38A10;SLC1A5;SLC6A13
prerank,tropomyosin binding (GO:0005523),-0.2461249534316739,-0.726771562575793,0.8736059479553904,0.9582174411779374,1.0,7/16,40.82%,NEBL;TMOD1;LMOD1;CALD1;TNNT3;S100A6;PYCARD
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.28338736924724317,0.726615167335487,0.8339483394833949,1.0,1.0,2/29,3.42%,ABHD10;GBA2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.2996581714981299,0.7225689657605381,0.8315282791817088,1.0,1.0,2/23,5.17%,WIPI1;SNX14
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3045105990473215,0.7195875515499026,0.836173001310616,1.0,1.0,9/18,23.39%,USP15;TGFB1;SMAD6;TGFBR1;TGFBR3;SMAD7;SMAD2;SMAD3;FKBP1A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3394791226039314,0.7184857934869033,0.804185351270553,1.0,1.0,5/10,24.60%,PIK3CB;PIK3C2B;PIK3C3;ATM;PIK3C2A
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3102240534888181,0.7161185386324044,0.8351063829787234,1.0,1.0,4/17,18.45%,AK4;AK5;AK3;CMPK1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2568008008831457,0.716099230859848,0.8729281767955801,1.0,1.0,5/55,6.25%,SLC6A11;SLC22A4;SLC16A12;SLC38A9;SLC7A2
prerank,protein kinase regulator activity (GO:0019887),0.24386037820035228,0.7157680906183266,0.9148264984227129,1.0,1.0,11/95,12.27%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;CCNC;MAPK8IP1;STK11;GPRC5B;SH3BP5L;CCNH;NPM1
prerank,anion channel activity (GO:0005253),0.2536576436385679,0.7151691351416074,0.8807947019867549,1.0,1.0,9/61,14.46%,BEST1;LRRC8A;VDAC2;CLCN4;CLIC1;GABRB3;VDAC1;CLCN7;GLRA1
prerank,semaphorin receptor binding (GO:0030215),-0.2226492823959152,-0.7138805277398472,0.8903508771929824,0.9679805397326501,1.0,17/23,43.08%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;PLXNB1;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F;SH3BP1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2894698830515577,0.713013037908138,0.8314176245210728,1.0,1.0,2/24,6.60%,GSDMD;PLEKHA3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.26432675723643234,-0.7128520834614851,0.8431952662721893,0.9631712372630231,1.0,3/13,8.34%,EZR;PRKAR2B;CSK
prerank,methyl-CpG binding (GO:0008327),0.2898256685584066,0.7123020575354815,0.8361508452535761,0.9999371148969375,1.0,6/22,19.34%,ZBTB38;PRMT5;PRMT1;MBD1;MECP2;TET1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.20671781590338736,-0.7108931227393068,0.9234449760765551,0.9593772126726826,1.0,17/27,36.71%,POLR3B;POLR3A;CRCP;PRIMPOL;MED20;POLR1F;POLR3H;PRIM1;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2475495213960348,0.7102308624524217,0.8928188638799571,1.0,1.0,14/74,17.28%,XYLB;GALK1;DCAKD;PANK4;COASY;FAM20C;PIK3CB;IPPK;PI4KB;NT5C3A;CHKB;PIK3C2B;PIK3C3;IPMK
prerank,death domain binding (GO:0070513),0.3341795322980797,0.7085803986202622,0.8229317851959361,0.9997384351416777,1.0,3/11,12.69%,BAX;BCL2;RACK1
prerank,cation transmembrane transporter activity (GO:0008324),0.2576562194891341,0.7076278166207272,0.8720271800679502,0.9985375963415631,1.0,7/48,14.36%,SLC38A9;SLC7A2;MMGT1;SLC39A1;SLC25A38;SLC41A1;SLC1A5
prerank,kinase activator activity (GO:0019209),-0.20319064524307398,-0.7068896724603859,0.9175257731958762,0.9583918243584705,1.0,3/30,2.43%,CAB39;STRADA;MARK2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.31286024006253976,0.7058373074521491,0.8168249660786974,0.9983175691862812,1.0,8/15,25.25%,PIK3CB;PI4KB;PIK3C2B;PIK3C3;PIKFYVE;ATM;PIK3C2A;PI4KA
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2782624692764848,0.70573273611371,0.8613861386138614,0.9961543398925342,1.0,5/27,14.06%,ITPR1;MMGT1;ATP2B1;KCNA1;SLC41A1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.22940850458684633,0.6992058289523121,0.9517102615694165,1.0,1.0,32/173,21.03%,POU6F1;NFKB1;ZNF25;ZEB2;MXI1;SNAI1;ZNF692;ZEB1;MXD1;ZBTB5;CC2D1A;NFX1;ZBTB20;YY1;NACC2;BACH1;PEG3;TRPS1;BCL6;SATB1;TCF3;GTF2IRD1;ZFP37;SOX13;ZFP90;ZNF177;MITF;E2F6;CTCF;ZNF219;ZBTB32;NFATC3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.33337701344018833,0.6986257731705563,0.8484848484848485,0.999449020349367,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3162474239393739,0.6955913676232833,0.818705035971223,1.0,1.0,2/12,12.03%,ISCA2;CISD1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3206581623703396,0.6954473719041347,0.8450292397660819,0.9982912165797819,1.0,2/11,17.73%,ITPR1;RASA3
prerank,cholesterol binding (GO:0015485),0.2533474128501702,0.692378384627815,0.8872266973532796,0.9993032174698577,1.0,13/47,22.04%,STARD5;ERLIN2;VDAC2;SOAT1;PTCH1;STARD3;VDAC1;SIDT1;SCARB2;OSBPL1A;NPC2;ABCG1;NPC1
prerank,death receptor activity (GO:0005035),0.3292383206192183,0.6920281039348061,0.8361153262518968,0.9974575168717563,1.0,2/11,12.49%,EDA2R;TNFRSF25
prerank,transcription coactivator binding (GO:0001223),0.2821026501348889,0.6890696522209311,0.8664921465968587,0.9984251243928518,1.0,3/20,8.26%,RORA;CDK9;CIT
prerank,N-acetyltransferase activity (GO:0008080),0.28766058299003755,0.68693452222994,0.8530559167750326,0.9983471914027399,1.0,2/19,6.77%,ATAT1;GNPNAT1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.24664543880230305,-0.6868613190638504,0.8857142857142857,0.973782715792137,1.0,3/15,7.94%,SOCS7;PIK3R3;SOCS4
prerank,lipase activity (GO:0016298),0.2547339695903058,0.6839318138903601,0.9087759815242494,0.9993313917991277,1.0,5/43,16.34%,LPL;SMPD2;PITPNM3;DDHD2;LDAH
prerank,chloride channel activity (GO:0005254),0.242084985818188,0.6814362116250985,0.9082872928176795,0.9995710815240475,1.0,8/59,14.46%,BEST1;CLCN2;CLCN4;CLIC1;GABRB3;TTYH2;CLCN7;GLRA1
prerank,O-methyltransferase activity (GO:0008171),-0.27294562187935195,-0.6796755566292366,0.8449367088607594,0.9745055904250793,1.0,7/10,42.48%,COQ3;CMTR1;MEPCE;FTSJ3;ASMT;BCDIN3D;CMTR2
prerank,cAMP response element binding (GO:0035497),-0.27252484255958487,-0.6750104650096079,0.8757763975155279,0.9730506779611166,1.0,5/10,25.65%,E4F1;CREB1;JUN;CREB3L1;HMGA2
prerank,hormone receptor binding (GO:0051427),0.297368839201332,0.6733688017952605,0.8691322901849218,1.0,1.0,1/14,3.71%,PTHLH
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.2694583160708812,-0.6723539232423393,0.8664383561643836,0.9696905460672268,1.0,1/11,0.75%,DAB2IP
prerank,PDZ domain binding (GO:0030165),0.23731070567799858,0.6719611659596104,0.9178532311062432,1.0,1.0,14/61,21.07%,SYNJ2;FZD3;SLC22A4;CIT;ATP2B1;TMEM88B;GRIA1;ARHGAP29;MAP2K2;NSF;PLEKHA1;TGFBR3;FZD2;ATP2B4
prerank,hydro-lyase activity (GO:0016836),0.24836385545341932,0.6700990476473271,0.8876013904982619,1.0,1.0,7/41,14.75%,HADHB;HSD17B4;ENO2;CDYL;PARK7;EHHADH;ECHDC1
prerank,MHC class II protein complex binding (GO:0023026),0.3164520584322942,0.6700369732923686,0.8674698795180723,1.0,1.0,1/11,2.67%,HSP90AA1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.30100222818850125,0.6691710464988749,0.8655692729766804,1.0,1.0,3/14,18.45%,AK4;AK5;CMPK1
prerank,NAD+ binding (GO:0070403),0.3026331465341618,0.668200983119633,0.8751793400286944,0.9993032952859265,1.0,3/12,15.97%,SIRT2;SIRT5;ZC3HAV1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.20977795168256164,-0.6668162169428934,0.9634703196347032,0.9688042727900301,1.0,9/21,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;POLE2;POLQ;POLK;POLI
prerank,mannose binding (GO:0005537),0.30963127392049794,0.6630005478287938,0.8690807799442897,1.0,1.0,1/12,8.24%,LMAN2L
prerank,ATPase regulator activity (GO:0060590),0.24552039295721376,0.6555421637649067,0.9112709832134293,1.0,1.0,11/38,22.09%,BAG1;BRSK2;KATNB1;HSPH1;DNAJB6;DNAJC24;DNAJC10;BAG4;TOR1AIP2;ATP1B2;SIL1
prerank,ribonuclease P activity (GO:0004526),0.3055426024128811,0.6537525704943862,0.8968133535660091,1.0,1.0,2/11,13.56%,PRORP;RPP30
prerank,translation elongation factor activity (GO:0003746),-0.2262752194600013,-0.6518019078137532,0.9133574007220217,0.9754414861531017,1.0,7/14,29.73%,EEF2;EEF1A1;GTPBP1;EIF5A;EIF5AL1;TSFM;EIF5A2
prerank,nucleotide diphosphatase activity (GO:0004551),0.2903952315384392,0.6514984967394173,0.8892005610098177,1.0,1.0,3/14,12.01%,NUDT12;NUDT3;ENPP1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.283633741728669,0.6493544221952131,0.8884297520661157,1.0,1.0,1/16,2.63%,NTHL1
prerank,single-stranded DNA helicase activity (GO:0017116),0.2717570575113177,0.6492756165132765,0.8977719528178244,1.0,1.0,1/19,2.77%,HELQ
prerank,NAD binding (GO:0051287),0.25388052148695733,0.6473535023544382,0.9111675126903553,1.0,1.0,5/26,16.05%,SIRT2;QDPR;SIRT5;ZC3HAV1;CTBP1
prerank,endoribonuclease activity (GO:0004521),0.24814592578079558,0.6440060300473992,0.9120750293083235,1.0,1.0,7/32,17.10%,LACTB2;RCL1;ENDOV;CPSF3;AGO3;SND1;ZC3H12C
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.2903781340662288,0.6438764222304106,0.8691860465116279,1.0,1.0,5/13,21.88%,GPSM1;GPSM2;ITGB1BP1;CCDC88A;GDI2
prerank,sodium:proton antiporter activity (GO:0015385),-0.25070961659320734,-0.6431561996112269,0.887905604719764,0.9760331528218682,1.0,2/11,9.74%,SLC9A2;SLC9B2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.28305926842398643,0.6426823264918344,0.8933143669985776,1.0,1.0,6/15,26.37%,SLC1A3;SLC1A5;SLC1A2;SLC38A7;SLC25A12;SLC17A6
prerank,endopeptidase activator activity (GO:0061133),-0.25928662915275674,-0.6426769450863529,0.9125,0.9706698275892847,1.0,6/10,31.33%,APH1A;VSIR;APH1B;PSME3;PSME1;PSENEN
prerank,ribonuclease P RNA binding (GO:0033204),-0.26489183104310005,-0.6423626535135007,0.9219653179190751,0.9653397513719977,1.0,6/10,37.58%,POP1;RPP14;RPP21;POP5;POP4;RPP38
prerank,carboxylic acid binding (GO:0031406),-0.17187380456194387,-0.641541841868803,0.9746835443037974,0.9603105973705109,1.0,12/38,29.68%,GRM7;UBR1;NOS3;PHYH;GLRA2;GLRB;SESN2;GLRA3;HIF1AN;NOS1;EPDR1;GLUD1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.23539072191184485,-0.6410667059692912,0.9230769230769231,0.9552473468470998,1.0,6/14,36.72%,KCNJ2;KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4
prerank,peptidase activator activity (GO:0016504),0.2607921481891731,0.6402208984620493,0.9161372299872935,1.0,1.0,3/22,10.21%,PCOLCE;VCP;PSME2
prerank,amino acid binding (GO:0016597),0.2501466086460116,0.6387752733121103,0.9201474201474201,0.999095289135627,1.0,5/31,18.27%,GRIN1;AARS1;GCLC;GLRA1;ASS1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.29913799040074374,0.6370203263357064,0.8787878787878788,0.9963489105936789,1.0,4/11,22.09%,BAG1;HSPH1;BAG4;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.29913799040074374,0.6370203263357064,0.8787878787878788,0.9963489105936789,1.0,4/11,22.09%,BAG1;HSPH1;BAG4;SIL1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2695471958801733,0.633963504269799,0.901749663526245,0.996730874278857,1.0,18/18,73.08%,RDH5;HSD3B1;HSD17B3;HSD17B6;RDH16;DHRS9;AKR1C1;HSD3B2;SRD5A2;HSD17B1;HSD17B14;HSD3B7;HSD17B2;HSD17B10;HSD11B1;HSD17B8;HSD17B7;DHRS11
prerank,lipoprotein particle receptor binding (GO:0070325),0.24277786819981056,0.6237417986214255,0.9193154034229829,1.0,1.0,6/27,17.19%,LRPAP1;LANCL1;SYT1;LRP1;HSPG2;APOE
prerank,potassium ion leak channel activity (GO:0022841),0.2714367339465913,0.6232352928808056,0.9090909090909091,1.0,1.0,1/15,5.33%,KCNK2
prerank,water transmembrane transporter activity (GO:0005372),0.2878503111219403,0.6153661201590801,0.9044862518089725,1.0,1.0,1/11,14.55%,AQP4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2340143724941968,0.61007182539384,0.9446494464944649,1.0,1.0,8/32,19.34%,KDM7A;KDM2B;ALKBH3;EGLN2;BBOX1;FTO;ALKBH1;TET1
prerank,neuropeptide receptor activity (GO:0008188),0.23903568785455256,0.6095573313731514,0.942189421894219,1.0,1.0,2/29,8.05%,HCRTR2;GPR37
prerank,cyclic nucleotide binding (GO:0030551),0.2561945152186246,0.6075791017163052,0.9247730220492867,1.0,1.0,4/21,19.08%,PDE4A;PDE10A;PDE4B;KCNH1
prerank,voltage-gated ion channel activity (GO:0005244),0.27248070231350136,0.6050687888625318,0.9227586206896552,1.0,1.0,3/14,18.02%,VDAC2;VDAC1;PKD2
prerank,kinase activity (GO:0016301),0.20466704766069646,0.6047546899598537,0.9773429454170958,1.0,1.0,27/109,22.67%,COQ8B;CDKL5;TAOK1;CDK5;DCAKD;ABL1;PANK4;COASY;PIK3CB;IPPK;PI4KB;CHKB;CKB;PIK3C2B;PIK3C3;IPMK;IP6K1;NEK1;PGK1;PAPSS1;DGKI;LYN;MAP4K4;TAF1;PSTK;NADK2;EPHA4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.1848441070515847,-0.6038651478850344,0.9815668202764977,0.9728541367866752,1.0,9/24,35.68%,KCNJ2;ABCC9;KCNJ3;KCNK1;KCNJ12;KCNN3;KCNK6;KCNJ8;KCNJ15
prerank,organic cation transmembrane transporter activity (GO:0015101),0.26198827304158834,0.6028854337637767,0.9195561719833565,0.9999844614259465,1.0,3/16,20.66%,SLC22A4;SLC44A2;SLC44A1
prerank,magnesium ion binding (GO:0000287),0.19950100061029222,0.6024519569158023,0.9786802030456853,0.9982012496475083,1.0,27/135,20.41%,NUAK2;TKT;ABL1;PPA2;STK11;BRSK2;RAP2A;SIK1;DHX36;NUDT12;BRSK1;NUDT3;ENDOV;TDP2;HPRT1;GCLC;EYA2;EPHX2;DIS3L2;NT5C3A;TPPP;OXSR1;SRPK1;CDC42BPB;MTPAP;IMPA1;PDCD6
prerank,voltage-gated sodium channel activity (GO:0005248),0.24885926369052366,0.599806011908272,0.9320512820512821,0.9978678681705345,1.0,3/22,10.99%,SCN7A;SCN2B;SCN1A
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.25136964710635423,0.5971007483723489,0.9268929503916449,0.9974141329885374,1.0,3/18,13.07%,PIK3R1;PIK3R2;WDR91
prerank,ADP binding (GO:0043531),0.2366314429733151,0.5944664453666784,0.943109987357775,0.9970181834757464,1.0,8/25,21.80%,MYH10;GCLC;PPP5C;PGK1;PRKAG2;ME1;ABCG1;MYH9
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.23652761401693145,0.5841030514939789,0.9448717948717948,1.0,1.0,5/22,17.19%,LRPAP1;LANCL1;SYT1;HSPG2;APOE
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22291894503459878,-0.5835465982865734,0.9669669669669669,0.9768063237814991,1.0,2/11,7.18%,NUDT5;DCPS
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.25744066306668334,0.5782022165933436,0.9462809917355371,1.0,1.0,15/15,74.28%,SAP30L;LANCL2;SH3PXD2B;SESTD1;PLEKHA5;PLCZ1;OBSCN;VEPH1;RUBCNL;PHLDA3;SNX3;PLA2G4E;PLA2G4A;JPH2;PLEKHF1
prerank,sulfotransferase activity (GO:0008146),0.2205998027121709,0.5781195943143302,0.9556354916067147,1.0,1.0,2/33,6.08%,HS2ST1;CHST10
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.20514348426520304,0.5755626931325293,0.9845132743362832,0.9995050078202163,1.0,6/53,14.36%,SLC7A11;SLC38A9;SLC7A2;SLC25A38;SLC1A3;SLC1A5
prerank,microtubule minus-end binding (GO:0051011),0.26244404151926504,0.5705170780897797,0.9486823855755895,1.0,1.0,4/13,22.15%,CAMSAP2;NUMA1;TUBGCP2;CAMSAP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.22391902491778423,0.5690677329003836,0.9683698296836983,0.9986533159725406,1.0,9/28,24.25%,PAK3;MAP2K2;RPS6KA1;MAP2K7;MAP2K3;MAP2K1;MAP2K6;SGK1;RPS6KA2
prerank,miRNA binding (GO:0035198),0.2196714348290781,0.5671347406919965,0.9764851485148515,0.9976141879879539,1.0,9/30,22.97%,ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,sequence-specific mRNA binding (GO:1990825),0.2720384452398983,0.5665145752720163,0.9453471196454948,0.9959077304109547,1.0,2/10,16.79%,SHFL;FMR1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.21067346393139744,0.564575859902781,0.9617224880382775,0.9948518432690158,1.0,3/35,8.95%,ABL1;SRMS;TEC
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.2632209774726971,0.5640997729712457,0.9413447782546495,0.9930690365114982,1.0,4/11,22.60%,DPAGT1;PTDSS1;PTDSS2;SAMD8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21759132024656444,0.5576389935888278,0.9662921348314607,0.9940368724847019,1.0,5/28,16.22%,PRORP;ENDOV;AGO3;RPP30;NUDT16L1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.22083481571866204,0.5522733490304648,0.9722572509457755,0.9942556449642764,1.0,6/24,22.95%,ZDHHC3;GLUL;ZDHHC17;ZDHHC2;ZDHHC14;ZDHHC21
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.1903730253921325,0.5467581806505175,0.9859002169197397,0.9945204903011473,1.0,5/69,7.58%,MOGAT3;CERS2;NMT1;SOAT1;ZDHHC3
prerank,FMN binding (GO:0010181),0.24457930450160026,0.5247627048831842,0.9597014925373134,1.0,1.0,1/11,6.76%,POR
prerank,chemokine activity (GO:0008009),0.20250950431675793,0.5182845624837742,0.9851301115241635,1.0,1.0,1/31,4.50%,CXCL12
prerank,myosin binding (GO:0017022),0.18036415874501427,0.5030887171399352,0.9910112359550561,1.0,1.0,12/55,22.41%,CXCR4;NCKIPSD;RAB10;RAB3B;MOBP;RAB8A;TRAK1;KIRREL1;RAB6A;GSN;LLGL1;RAB11B
prerank,potassium:proton antiporter activity (GO:0015386),0.23465284754590426,0.5002066713184112,0.9738863287250384,1.0,1.0,4/10,25.79%,SLC9A7;SLC9A6;SLC9A9;SLC9A1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.20192222624308875,0.4949153698321279,0.9821656050955414,1.0,1.0,5/24,18.45%,AK4;AK5;AK3;IP6K1;CMPK1
prerank,CCR chemokine receptor binding (GO:0048020),0.18841207580585326,0.4810525231615144,0.9900744416873449,1.0,1.0,6/28,26.04%,NARS1;CCL25;NES;CX3CL1;CNIH4;CCL14
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.19452222601397207,-0.4782525163042349,0.9970149253731343,1.0,1.0,5/10,40.93%,B4GALT6;B4GALT7;B3GALT2;A3GALT2;B3GALT6
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.20963787377204268,0.47742389690201786,0.9829302987197724,0.9998546518054686,1.0,2/14,13.56%,PRORP;RPP30
prerank,BMP binding (GO:0036122),-0.18987175030981485,-0.4771850602103053,0.9852941176470589,0.9946537643264017,1.0,1/11,7.62%,ENG
prerank,chemokine receptor binding (GO:0042379),0.18173257525217784,0.474929200920046,0.9963592233009708,0.9982965834404095,1.0,1/35,4.50%,CXCL12
prerank,protein phosphatase 1 binding (GO:0008157),0.19316651714694258,0.47136345237163385,0.9933862433862434,0.9969291208622213,1.0,3/21,17.75%,PPP1R9B;PPP1R16A;PPP1R11
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.22067854048298946,0.4711155478998232,0.9880952380952381,0.995016544791274,1.0,1/11,12.11%,KCND3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.19994521207029642,0.44069378733582043,0.9941605839416059,0.9971778175958897,1.0,6/12,26.89%,TENT5A;MTPAP;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.1950574845944837,0.4051453265534141,0.9969465648854962,0.9979387115113059,1.0,2/10,21.07%,DCLRE1A;EXD2
